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Intracortical microelectrode arrays create a direct interface between the brain and 
external devices.  This “brain-machine interface” has found clinical application by 
allowing patients with tetraplegia to control computer cursors and robotic limbs.  
Unfortunately, use of intracortical microelectrode array technology is currently limited by 
its inconsistent ability to record neural signals over time.  It is widely believed that the 
foreign body response (FBR) contributes to recording inconsistency.  Most 
characterizations of the FBR to intracortical microelectrodes have been in the rat using 
devices with simple architecture, while the only device currently used in humans, the Utah 
Electrode Array (UEA), is much larger and more complex.  In this work, we characterized 
the FBR to the UEA and found that, unlike with simpler devices, implantation of a UEA 
results in extensive vascular injury and loss of cortical tissue.  We also sought to determine 
which features of the FBR correlated with recording inconsistency and found that 
biomarkers of astrogliosis, blood-brain barrier leakage, and tissue loss were associated with 
decreased recording performance.  Next, since a significant portion of potential brain-
machine interface recipients are aged, we applied similar methods in an aged cohort of rats 
in order to understand the effect of aging on the FBR and recording performance.  We 
found that, surprisingly, recording performance was superior in the aged cohort.  
Astrogliosis was again associated with decreased recording performance in the aged 
cohort.  Finally, we continued our development and validation of a finite element model of 
 iv 
cytokine diffusion to assist in designing next-generation devices with a reduced FBR.  
Taken as a whole, this work provides meaningful insights into the mechanisms of 
inconsistent recording performance and discusses several promising avenues for 
overcoming them.
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1.1 Clinical Populations 
Paralysis and limb loss can be extremely debilitating, completely changing a patient’s 
ability to interact with the world.  One in fifty Americans currently suffer from some form 
of paralysis, with 17% reporting “a little difficulty” in moving, 29% “some difficulty,” 
36% “a lot of difficulty,” and 16% “completely unable to move” a part of their body [1].  
The most common causes of paralysis are stroke, spinal cord injury (SCI), and multiple 
sclerosis [1].  The etiologies of paralysis are summarized in Fig.  1.1.  Paralysis is typically 
incurable due to the limited regenerative capacity of human CNS tissue.  For example, in 
a database of 13,000 SCI patients, 46% had complete (motor and sensory) paralysis upon 
admission and 42% still had complete paralysis at discharge from rehabilitation [2].  Less 
than 1% of SCI patients obtain complete neurologic recovery after rehabilitation [2]. 
Limb loss currently affects 1 in 190 Americans [3].  The prevalence of limb loss by 
type and etiology is summarized in Table 1.1.  Our inability to regrow limbs and the 
difficulties inherent in limb transplantation make limb loss a similarly incurable condition.  
In the absence of a cure, patients with paralysis or limb loss often use assistive technologies 
to augment their abilities as much as possible.  Examples of these technologies include 









Table 1.1.  Etiology of limb loss by type.  Minor limb loss refers to loss of fingers or toes 
only.  Estimated prevalence in the United States can be calculated by multiplying by 
1,568,000.  Derived from data in [3]. 
 










100.0% 39.7% 25.8% 2.6% 31.9% 
Dysvascular 
Disease 
54.0% 32.1% 19.3% 0.3% 2.2% 
Trauma 44.9% 6.8% 6.4% 2.2% 29.6% 


























invaluable to patients, do not approach the exquisite capabilities of natural motor control.  
The field of brain-machine interfaces seeks to change that. 
 
1.2 Brain-Machine Interfaces 
Brain-machine interfaces (BMIs), also called brain-computer interfaces (BCIs), can 
give patients volitional control over prosthetic devices.  As one example, BMIs can restore 
upper limb function in people with complete tetraplegia from SCI.  To do so, an 
intracortical microelectrode array is placed in the patient’s motor cortex in order to detect 
neuronal electrical signals.  Then, the patient imagines moving their (paralyzed) arm.  
Neurons in the motor cortex of the patient’s brain send signals using action potentials.  In 
a healthy patient, these signals would propagate to neurons in the spinal cord, then muscles 
in the arm, and a movement would take place, but for a patient with SCI, the signals cannot 
travel down the spinal cord and no movement takes place.  Instead, in this patient, the 
intracortical microelectrode array records neural activity, passes this information to a 
computer, and the computer interprets the signals and translates them into movement of a 
robotic arm.  With practice, both the computer and the patient learn to communicate more 
efficiently with one another, ideally to the point that the patient can move the robotic arm 
as if it were their own. 
BMIs of this sort have been successfully achieved in humans [4, 5] but have yet to enter 
widespread clinical use.  Besides recording signals related to upper limb movement, BMIs 
have also been used in humans to collect speech information [6].  Investigators are also 
exploring the possibility of using signals from a BMI to control electrical stimulation of 
peripheral nerve or muscle tissue, causing specific muscles in the paralyzed arm or leg to 
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contract and avoiding the need for a robotic appendage [7]. 
BMIs can also function in the reverse direction, i.e., to send information directly into 
the brain by electrically stimulating neural tissue and inducing action potentials to occur.  
So far, this type of BMI has been used to provide a crude level of vision in humans [8].  
BMIs could combine recording and stimulating functionality, allowing for a robotic arm 
with the ability to feel [9], or a memory prosthesis for patients with neurodegenerative 
diseases [10].  It is also important to note that the microelectrode arrays used to interface 
with the brain are very similar to devices used to interface with other parts of the body such 
as the cochlea [11] and the retina [12] to provide hearing/vision and peripheral nerves to 
record motor intent [13], induce somatosensation [14], and trigger skeletal [7] or sphincter 
muscle contraction [15].  Thus, hardware improvements in any of these applications have 
the potential to translate to the others. 
The hardware used to interface with the brain varies according to the density of 
information needed to control the device.  A binary yes/no signal roughly once per second 
is a sufficient data rate for patients to spell words letter by letter, and this low density of 
information can be obtained simply by placing electrodes on the scalp and recording large-
scale neural oscillations [16].  Meanwhile, control of a multiple degree-of-freedom robotic 
arm requires hundreds of signals to be supplied continuously [17], which is obtained using 
microelectrode arrays implanted directly into cortical tissue.  The tradeoff for obtaining a 
high density of neural information with a device implanted in cortical tissue is that the 
patient must undergo brain surgery and tolerate a foreign body in their brain, both of which 
pose risks to the patient.  Electrocorticography (ECoG) or micro-electrocorticography 
devices, which rest on the surface of the brain, are seen as an intermediate between these 
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two paradigms in terms of information density and surgical risk [18]. 
The focus of this dissertation is on microelectrode arrays implanted into cortical brain 
tissue.  These devices have the potential to extract the highest density of information and 
have the highest potential to restore complex abilities such as upper limb movement with 
high fidelity.  At the same time, these devices also have the greatest potential to be 
influenced by biological events. 
 
1.3 Intracortical Microelectrode Arrays 
Intracortical microelectrode arrays generally fall into three design paradigms: 
microwires, planar silicon devices, and Utah Electrode Arrays (UEAs) (Fig. 1.2). 
Microwires are the oldest and simplest design [19, 20] and are still used successfully 
in a wide variety of animals today. The design consists of wires with an electrically 
conductive core (e.g., tungsten) and an insulating coating (e.g., parylene-C).  The tips of 
the wires are cut and sometimes sharpened.  When inserted into brain tissue, electrical 
activity of neurons near the conductive tip can be recorded.  A variety of materials and 
sizes have been used.  Microwire electrodes can be assembled into arrays of microwires 
that are inserted all at once into brain tissue, or alternatively, into arrays that allow for 
individual positioning of microwires.  Tucker Davis Technologies (Alachua, FL), 
MicroProbes (Gaithersburg, MD), FHC (Bowdoin, ME), and Plexon (Dallas, TX) sell 
microwire arrays, although some labs fabricate their own in-house [21-23]. 
Planar silicon or “Michigan” devices are created from silicon wafers using 
microfabrication techniques and can be designed to have recording sites not just at the tip, 




Fig. 1.2.  Various designs of intracortical microelectrodes.  (A) Single microwire electrode.  
(B) Single-shank planar silicon electrode.  (C) Microwire array.  (D) Multishank planar 





fabricated with multiple “shanks” with recording sites along the length of each shank, 
allowing the device to record from multiple locations in the brain at multiple depths.  These 
can then in turn be stacked into a holder to record from a 3D volume of tissue.  Planar 
silicon arrays are currently manufactured by NeuroNexus (Ann Arbor, MI) and FHC 
(Bowdoin, ME). 
UEAs were developed at the University of Utah [26].  These devices are also fabricated 
from silicon wafers, but rather than creating the device on the surface of the wafer, a dicing 
saw is used to make a grid of deep cuts into the wafer, and then the square pillars that 
remain are chemically etched to form slender shafts.  The tip of each shaft is able to record 
from nearby neurons, similar to a microwire array.  The UEA is the only intracortical 
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microelectrode array that has been implanted chronically in humans [4, 5, 27].  Blackrock 
Microsystems (Salt Lake City, UT) currently manufactures devices of this design. 
 
1.4 Recording Inconsistency 
Intracortical microelectrode arrays will need to record neural signals from patients 
reliably for decades before they see widespread clinical use.  A device that fails 
unexpectedly or that needs frequent replacement over time is clinically infeasible due to 
the risk and expense of brain surgery. 
Examples of BMI performance multiple years after implantation of the microelectrode 
array exist for nonhuman primates [28-30] and humans [4, 27, 31].  Due to the effort and 
expense involved with training each subject, these studies have very small N (one, three, 
and two in [28-30], and one, two, and one in [4, 27, 31], respectively).  Moreover, since 
the emphasis of such studies is on characterizing a working BMI, failures of any other 
subjects are not often discussed.  Meanwhile, in studies where microelectrodes are used to 
simply record neural activity but not drive a BMI, it is feasible to use large cohorts of 
smaller animals and characterize device failure rates and longevity for the whole cohort.  
These large-N studies reveal that while microelectrodes can function for multiple years, 
the majority cease recording single unit action potentials much earlier, and those that do 
not fail typically experience unpredictable fluctuations and a gradual decrease in 
performance with time in mice [32], rats [33-36], guinea pigs [22], and cats [23, 37, 38]. 
Thus on the one hand, there are reports of successful BMI performance over multiple 
years in humans and nonhuman primates, and on the other, frequent failures and 
unpredictable performance in smaller animals. Two retrospective studies of work 
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performed in nonhuman primates help reconcile this discrepancy.  Barrese et al. in 2013 
compiled data from UEAs in 27 macaques over 17 years of experiments in the Donoghue 
lab [39].  This study reported failures (Fig. 1.3), fluctuations, and gradual decreases (Fig. 
1.4) similar to studies in smaller animals.  This study did not perform any histological 
analysis.  A retrospective study by Schwarz et al. in 2014 compiled data from microwire 
arrays in eight rhesus monkeys over seven years of experiments [40].  This study did not 
provide data on reasons for terminating experiments with any of the subjects, did not say 
whether any animals were excluded due to early failures, and presented histology for only 
one animal.  However, this study reported an overall higher degree of reliability and 
longevity than in most studies, albeit with similar fluctuations over time.  These studies 
show that recording inconsistency is not unique to small animals – although it may be 
exacerbated in them – and that the high performance in BMI nonhuman primate studies 
 
Fig. 1.3.  Recording longevity of 62 UEAs implanted in 27 macaques, compiled 
retrospectively from 17 years of experiments.  After one year, 17 of the initial 62 devices 
are still functional.  A few devices were able to record for many years, however.  Figure 






Fig. 1.4.  Recording performance (number of electrodes able to record single unit action potentials) of 62 UEAs implanted in 27 
macaques, compiled retrospectively from 17 years of experiments.  Each of the shapes/colors of markers represent different arrays listed 
in the figure legend.  The black line represents the average for all arrays in a 14-day bin.  Bin boundaries are shown as red hatch marks 
on the horizontal axis.  Red line represents a linear regression.  Note the high degree of variability in performance between animals and 







is likely partly explained by selection bias.  Thus, recording inconsistency is considered a 
significant problem facing BMI development. 
 
1.5 Mechanisms of Recording Inconsistency 
A number of mechanisms have been proposed to explain recording inconsistency in 
intracortical microelectrode arrays.  These mechanisms can be divided into two categories: 
device-related failure modes and biological failure modes. 
Device-related failure modes include failures due to breakage or deterioration of the 
microelectrode itself.  Detachment of the percutaneous connector from the skull is one 
common problem [22, 33, 39].  Breakdown of insulation materials, corrosion of electrode 
tip metal, and ingress of moisture into connector components have been reported [35, 36, 
39].  The push toward wireless technology and advances in electrode materials and 
manufacturing techniques will likely reduce the rates of these failures. 
Biological failure modes are a greater barrier to clinical usage since their mechanisms 
remain poorly understood.  In order to record single unit action potentials, the recording 
site of a microelectrode must be within about 100 µm of a neuron’s cell body when the 
neuron fires an action potential [41].  Therefore, if all neurons are killed within the first 
100 µm, there will be no action potentials for the device to detect.  Even if living neurons 
are present within 100 µm, if they become silenced by unfavorable extracellular conditions 
or lose connections to appropriate cortical circuits, the device will also fail to record useful 
action potentials.  Another biological failure mode is if the device is pushed or pulled away 
from the cortical layers it is attempting to record from due to fibrotic tissue buildup under 
the array or settling of the array down into the brain, which has been reported in cats [37, 
11 
 
38] and nonhuman primates [39].  Although it is currently unknown which of these 
processes are most responsible for recording inconsistency, all of these processes are linked 
to the foreign body response (FBR). 
 
1.6 The Foreign Body Response 
A brief overview of the events of the FBR to medical devices in general will be 
provided here. 
First, the implantation of a medical device necessarily involves tissue injury in order to 
position it within the target tissue [42].  This severs blood vessels, releasing blood into the 
extracellular space.  The coagulation cascade and platelet aggregation stop bleeding and 
restore homeostasis [43].  Cells close to the injury may apoptose and/or necrose in response 
to the mechanical injury itself or to the altered extracellular milieu.  Foreign pathogens may 
also be introduced by the injury. 
Molecules from platelets, damaged blood vessels, apoptotic/necrotic cells, foreign 
pathogens, and the complement cascade [44] all trigger the multifaceted biological 
response known as inflammation.  Mast cells, dendritic cells, and tissue-resident 
macrophages in the injured tissue are sensitive to these signals and become activated, 
releasing additional cytokines and signaling molecules [42, 45].  Molecules such as 
prostaglandins, histamines, and nitric oxide increase local blood flow and blood vessel 
permeability, causing the clinical hallmarks of inflammation: swelling, redness, heat, and 
pain [46].  Other cytokines attract neutrophils in the bloodstream to enter the tissue and 
phagocytize bacteria [47].  Neutrophils arrive within hours, and are characteristic of acute 
inflammation.  After a few days, infiltrating lymphocytes and monocytes become more 
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predominant and the tissue transitions into chronic inflammation [47].  Once in tissue, 
monocytes mature into macrophages, which specialize in phagocytizing cellular debris and 
pathogens.  Neutrophils and macrophages produce reactive oxygen species (ROS) that 
assist in killing and breaking down pathogens [48].  Neutrophils, lymphocytes, and 
macrophages not only respond to proinflammatory cytokines but produce their own 
proinflammatory cytokines, further escalating inflammation [42].  They are also capable 
of secreting anti-inflammatory cytokines, which are important for modulating the types and 
activation states of immune cells present and for preventing an excessive response.  Anti-
inflammatory cytokines assist in transitioning to the final stages of wound healing, where 
angiogenesis, proliferation of non-immune cells, and remodeling of the extracellular matrix 
(ECM) restore the tissue to its original state or to a stable scar [49, 50]. 
When an indwelling device is present, however, complement proteins, 
immunoglobulins, and other proteins interacting with the device’s surface provide a 
continuous inflammatory stimulus [44].  Macrophages experience frustrated phagocytosis 
if the device is resistant to oxidative and enzymatic digestion and is too large to engulf.  
This causes them to enter activation states normally employed against multicellular 
parasites, and to fuse into large, multinucleated foreign body giant cells [51].  The nearby 
tissue remains in a persistently inflamed state, and often develops a fibrous capsule 
between the device/macrophages and the tissue [42].  Persistent inflammation and fibrous 
capsule formation can be problematic for the health of the patient and the functioning of 




1.7 The FBR to Intracortical Microelectrodes 
In the decades since the first report by Collias and Manuelidis in 1957 [52], dozens of 
studies have been published describing the implantation injury and FBR to a variety of 
designs of intracortical microelectrodes in many different animal models [52-69].  The 
typical distribution of FBR biomarkers are summarized in Fig. 1.5 and discussed below. 
The implantation of the microelectrode into the brain severs blood vessels, causing 
bleeding and edema [63, 69, 70].  If a device with one or a few shanks is inserted and then 
immediately withdrawn, this initial injury or “stab wound” is small enough to be able to 
heal over the course of about four weeks, potentially with some residual astrocytic scarring, 
or astrogliosis, but little other signs of inflammation [53, 59, 71, 72].  In healthy tissue, 
astrocytes participate in the maintenance of homeostasis, regulation of vascular function, 
modulation of neuronal synapses, and information transmission via intracellular calcium 
waves [73-75].  In response to inflammation, astrocytes proliferate, thicken their processes, 
produce additional cytoskeletal filaments such as glial fibrillary acidic protein (GFAP), and 
form scar tissue that can persist after the initial inflammatory stimulus has subsided [76].  
To date, the long-term result of a stab wound using a large, complex array like the UEA is 
unknown, and will be explored in Chapters 2-3. 
In contrast to a stab wound, when the microelectrode is left indwelling in the brain, 
classic hallmarks of the FBR develop over the first few weeks of implantation and stabilize 
roughly eight weeks after implantation.  Immediately adjacent to the device, a dense layer 
of activated macrophages forms [53-59].  Some of these cells appear to come from the 
brain’s population of tissue-resident macrophages, microglia, but most are from blood- 






Fig. 1.5.  Typical distribution of FBR biomarkers surrounding a single-shank planar silicon 
microelectrode.  Images are representative horizontal sections of rat brain tissue four weeks 
after implantation.  Activated macrophages (ED-1/CD68, red) are visible at the device-
tissue interface.  Surrounding the activated macrophage layer, hypertrophic astrocytes 
(GFAP, green) and reductions in neuronal nuclei (NeuN, blue) and neuronal processes (NF, 





These cells are typically identified using antibodies against ionized calcium-binding 
adapter molecule 1 (IBA-1), which is a calcium handling protein that is expressed 
specifically in macrophages (including microglia).  Their activated state is usually 
identified using antibodies against cluster of differentiation 68 (CD68) (also known as ED-
1), which is a glycoprotein expressed at high levels in the lysosomes of macrophages that 
are actively phagocytizing material.  Activated macrophages have also been found adhered 
to devices withdrawn from the brain [53-55].  In most of these reports, there are more 
activated macrophages in the brain tissue than on the withdrawn devices.  Activated 
macrophages on explanted devices have been cultured in vitro and found to release the 
cytokines tumor necrosis factor alpha (TNF-α) and monocyte chemotactic protein 1 (MCP-
1) (Fig. 1.6) [53]. 
Surrounding the activated macrophage layer is a region of astrogliosis and decreased 
neuronal nuclei and processes [52-62, 67, 78].  GFAP is the most common antibody target 
for identifying astrogliosis.  Antibodies against various targets are used to identify neurons, 
including neuronal nuclei (NeuN) for neuronal cell nuclei, neurofilament 200 (NF200) for 
axons, and neurofilament 160 (NF160) for axons and dendrites. Axons in this region have 
also been reported to become demyelinated, as indicated by a lack of immunoreactivity for 
myelin markers in areas positive for axons [56]. 
Blood plasma proteins such as immunoglobulin G (IgG) are typically excluded from 
the brain parenchyma by the blood-brain barrier (BBB), but when the BBB is compromised 
near an inflammatory stimulus, these proteins can leak out into brain tissue.  IgG, along 
with other plasma proteins such as fibrinogen, can trigger cell signaling cascades in 








Fig. 1.6.  Explanted planar silicon microelectrode cultured in vitro and labeled for activated macrophages (CD68) and cell nuclei 
(DAPI), shown under brightfield (A) and fluorescent (B) illumination.  (C-D) Macrophages on explanted devices released MCP-1 and 








plasma proteins, as well as changes in extracellular ionic concentrations that would be 
expected to coincide with their presence, may lead to neuronal degeneration and 
dysfunction [79]. 
Most of the existing literature on the FBR to intracortical microelectrode arrays has 
been conducted in the rat using simple devices with one or a few penetrating features.  
Meanwhile, the only device used clinically in humans is the much larger and more complex 
UEA.  Chapters 2-3 make a unique contribution to this literature by providing the first in-
depth characterization of the FBR to a large, complex, clinically relevant device such as 
the UEA in a rat model. 
 
1.8 Relationships between the FBR and Recording Performance 
Based on the literature described thus far, the FBR’s causative role in recording 
inconsistency appears to be an attractive hypothesis.  In recent years, investigators have 
begun the process of directly testing this hypothesis.  If the FBR is responsible for 
recording inconsistency, it may be possible to directly correlate one or more features of the 
FBR with recording performance.  These correlations may exist on an animal-to-animal 
basis (i.e., animals with a more severe FBR have reduced recording performance) or on an 
electrode-to-electrode basis (i.e., specific electrodes on an electrode array have a more 
severe FBR and reduced recording performance).  Four studies, to our knowledge, have 
taken this approach of quantifying features of the FBR and correlating them with recording 
performance within a single cohort of animals. 
The earliest study was by Freire et al. in 2011 from the Nicolelis lab [34].  In this study, 
24 rats were implanted with microwire arrays, recorded from weekly, and sacrificed at 
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various time points from 1-24 weeks.  Recording performance was highly variable across 
animals and time, but generally decreased with time.  Immunohistochemical labeling of 
activated macrophages (CD68), apoptosis (caspase-3), calcium-dependent neural activity 
(early growth response protein 1 or EGR-1), neural activity in nitric oxide-producing 
neurons (nicotinamide adenine dinucleotide hydrogen phosphate diaphorase or NADPH-
d), and metabolic activity (cytochrome oxidase) were quantified in a 141x141 µm square 
region around each electrode and correlated with recording performance (median action 
potential firing rates) from each week of recording.  The authors concluded that all of these 
markers correlated well, but their data show strong correlations some weeks and weak 
correlations other weeks, and the patterns in timing are not consistent across animal 
groupings (Fig. 1.7).  They also report that NADPH-d and cytochrome oxidase levels near 
electrodes were not statistically different from contralateral, unimplanted tissue, which 
would seem to undermine the idea that these markers could be used to understand 
biological mechanisms of recording inconsistency.  Moreover, their quantification methods 
are atypical in the field and were inadequately described in the methods.  Their paper 
provides an excellent example of recording inconsistency in rats, but does not provide 
useful data regarding the correlation of the FBR and recording performance. 
Prasad et al. in the Sanchez lab in 2012 implanted microwire arrays in 25 rats for up to 
nine months [35].  The investigators immunohistochemically labeled macrophages (IBA-
1), activated macrophages (CD68 and OX-6), and ferritin.  Ferritin is an iron storage 
protein that is expressed in microglia when the BBB has been compromised and iron 
sequestration is needed.  They also analyzed scanning electron microscopy images of 





Fig. 1.7.  Correlations of recording performance with five different biomarkers of the FBR.  The horizontal axis is time in weeks.  Darker 
squares represent higher nonparametric Spearman correlation coefficient values (which ranges from 0 to 1 based on the strength of 
correlation, regardless of whether the correlation is positive or negative).  1, 2, 3, and 4 refer to the different times of sacrifice.  For 
example, for rats sacrificed at week 4, activated macrophages (ED-1) were highly correlated with performance in the first 3 weeks, and 
very poorly correlated in week 4.  Reprinted from [34] under a Creative Commons Attribution license, © 2011 Freire M.A.M., Morya 







recording session.  In addition, they quantified blood serum and cerebrospinal fluid (CSF) 
levels of phosphorylated axonal neurofilament subunit H (pNF-H), which is a byproduct 
of axonal injury.  The investigators did not present any statistical analysis of any of these 
metrics and instead relied on detailed descriptive qualitative analysis.  They found that 
extremely high or low impedance values were usually related to degradation of electrode 
materials.  They also found that high levels of pNF-H tended to correspond to reduced 
electrode performance.  In their histological analysis, ferritin tended to correspond to 
reduced performance, but the various macrophage markers did not appear to have any 
relationship to recording performance.  They also noted that greater amounts of bleeding 
at surgery led to reduced performance.  Considering all of these factors together, the 
authors came to the conclusion that consistent recording performance depends on a 
combination of minimal bleeding during surgery, good electrode material integrity, and 
low levels of axonal injury over the duration of the experiment.   Their conclusions are 
somewhat difficult to confirm, however, due to their presentation of histological 
quantification data in a table of 200 raw values and their presentation of combined analysis 
as a 3D scatterplot. 
In 2013, Saxena et al. in the Bellamkonda lab implanted 56 rats with either planar 
silicon or microwire electrode arrays for three days or 16 weeks [80].  Most of the paper 
was focused on comparing the FBR and performance of these two different electrode 
designs.  They found that microwire arrays were associated with reduced BBB dysfunction, 
increased matrix metalloproteinases 2 and 9 (MMP-2 and MMP-9), and increased 
performance relative to the planar silicon devices.  However, since these are different 
devices, factors related to the device instead of the FBR could have been responsible for 
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the difference in recording performance.  Therefore, within the microwire array cohort, 
they selected the animal with the highest performance and the animal with the lowest 
performance and found higher levels of IgG, reduced neuronal nuclei, and increased 
transcript levels for proinflammatory cytokines.  Not discussed was the additional presence 
of a large lesion in the brain near half of the electrodes in the low-performing animal.  
While this report supports the hypothesis that the FBR and recording performance are 
related, comparing just two animals is not statistically convincing. 
Prasad et al. in 2014 published a study similar in design to their 2012 study except with 
parylene-C insulated platinum-iridium microwires instead of polyimide insulated tungsten 
[36].  They reported that platinum-iridium was more resistant to corrosion than tungsten, 
though the insulation material still degraded.  They did not measure serum or CSF pNF-H 
levels.  They found similar relationships between impedance, recording performance, 
histological markers, and surgical bleeding as in their previous study; that is, high recording 
performance correlated with moderate electrode impedance, low levels of ferritin, and a 
low degree of bleeding at implantation.  Their conclusions are more easily confirmed in 
this study, as shown in Fig. 1.8.  There was no statistical analysis of correlation and the 
study was smaller (N = 12) than their previous study, but this study is perhaps the strongest 
existing evidence that the FBR is correlated with recording performance. 
In Chapters 2-3 in this work, we employ an approach similar to these four papers, but 
avoid their shortcomings by working within a single cohort, using established quantitative  









Fig. 1.8.  Correlations of recording performance with three different biomarkers of the 
FBR.  Individual animals are shown on the horizontal axis and grouped by implant 
duration.  Normalized levels of the biomarkers are shown on the vertical axis.  Symbols 
correspond to the authors’ notes on performance and device materials degradation in 
relation to the biomarker levels.  Reprinted from [36] under a Creative Commons 
Attribution license, © 2014 Prasad A., Xue Q.-S., Dieme R., Sankar V., Mayrand R.C., 
Nishida T., Streit W.J., and Sanchez J.C.  
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1.9 Aging and the FBR 
Patients with paralysis and limb loss span a wide range of ages.  The age distributions 
for people with paralysis and limb loss are shown in Figs. 1.9 and 1.10.  Notably, 33.5% 
of individuals with paralysis are over 60 years old [1], and 42% of individuals with limb 
loss are over 65 [3]. Furthermore, young patients receiving a BMI are likely to eventually 
reach old age. A 20-year-old patient with high tetraplegia due to spinal cord injury who 
survives the first year after injury has a life expectancy of 57 years [81]. 
There is a remarkable lack of studies directly comparing the FBR to medical devices 
in young and aged animals [82].  However, numerous studies have examined the effects of 
aging on the immune system, the brain, and the brain’s responses to injury and 
inflammation.  These studies lead one to expect that the implantation injury and FBR would 
be increased when a microelectrode array is implanted into the aged brain. 
Immunosenescence refers to the changes that occur in the immune system during 
normal aging. Numbers of naïve B and T lymphocytes are decreased and neutrophils and 
macrophages have a reduced capacity for phagocytosis and ROS production, decreasing 
the immune system’s effectiveness at clearing pathogens [83, 84].  The influence of aging 
on cell signaling pathways is complex [83, 84], having the somewhat paradoxical effects 
of decreasing immune effectiveness but increasing overall levels of proinflammatory 
cytokines such as interleukin 1β (IL-1β) [85], interleukin 6 (IL-6) [86-89], and tumor 
necrosis factor alpha (TNF-α) [88, 90-93].  Decreased immune effectiveness and increased 
proinflammatory cytokines due to immunosenescence are believed to play a role in type 2 
diabetes [90], atherosclerosis [93, 94], Alzheimer’s [95], Parkinson’s [88], osteoporosis 
































Aging also affects the brain.  Microglia acquire a more reactive phenotype [99].  Their 
morphology becomes less ramified and more amoeboid [100-102]. They express increased 
markers of activation such as major histocompatibility complex (MHC) class II, cluster of 
differentiation 45 (CD45), and CD68 [101-103].  They also produce higher levels of 
proinflammatory cytokines such as IL-1β, IL-6, and TNF-α [100, 103, 104].  Astrocytes 
undergo changes as well, becoming more numerous and hypertrophic [105].  Mild neuronal 
cell death and reductions in dendrites and synapses occur naturally [106].  The risk of 
developing neurodegenerative diseases such as Alzheimer’s [107] and Parkinson’s [108] 
disease increases dramatically with aging. 
Immunosenescence and the aging of the brain affect the brain’s ability to respond to 
injuries.  Aged patients have poorer clinical outcomes following ischemic stroke [109], 
traumatic brain injury [110], and aneurysmal subarachnoid hemorrhage [111].  Rodent 
models of brain injury show increased neural tissue loss following experimental brain 
injuries in aged rodents [112, 113]. 
Due to these factors, the injury caused by microelectrode array implantation may be 
greater in aged patients.  Furthermore, the increases in proinflammatory cytokines, reactive 
microglial phenotypes, and neurodegeneration may exacerbate the neuroinflammatory 
sequelae associated with indwelling microelectrodes.  However, no studies to our 
knowledge have examined the FBR to microelectrodes in aged animals.  Fig. 1.11 shows 
the ages of rats used in 41 studies of the FBR to microelectrodes in the rat brain.  The 
preference for young adult rats in these studies is likely to save costs. 





Fig. 1.11.  Ages of rats used in 41 studies of the FBR to microelectrodes in the rat brain.  
The vast majority of studies used rats in early adulthood and no studies used rats of mid-
age or old age. 
 
 
subjects in published reports of BMIs in humans are 25 [27], 58 [4, 31], 66 [4], and 52 [5].  
Since so few subjects have received BMIs so far, it is not known whether there are 
systematic differences in the recording performance of microelectrodes in aged versus 
young humans.  The FBR to microelectrodes has not yet been evaluated in human patients. 
The closest available literature, then, is arguably that on deep brain stimulation (DBS) 
electrodes.  DBS electrodes are larger, single-shank devices implanted into deep brain areas 
as a treatment for drug-unresponsive Parkinson’s disease.  DBS electrodes are associated 
with increased rates of complications [114], somewhat decreased clinical benefit [115-
117], and increased rates of cognitive and behavioral impairments [117] in aged patients. 
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We are not aware of any studies comparing the FBR to DBS electrodes in young and aged 
patients. 
Based on existing literature regarding immunosenescence, the aging of the brain, 
clinical outcomes following brain injury, and clinical data on DBS electrodes, it is likely 
that the implantation injury and FBR to intracortical microelectrodes is exacerbated in aged 
animals.  The literature discussed in the previous section furthermore suggests that 
increased injury and FBR would likely lead to reduced performance.  Understanding 
whether this is the case – and if so, why – may lead to development of strategies that 
improve microelectrode performance in aged subjects.  In Chapter 3, we present the first 
study of intracortical microelectrodes in aged animals. 
 
1.10 Strategies to Reduce the FBR to Intracortical Microelectrodes 
Numerous investigators began developing ways to reduce the FBR to intracortical 
microelectrodes even before the correlation studies reviewed in Chapter 1.8.  A wide 
variety of strategies have been employed with varying degrees of success.  Here, we review 
studies which implanted microelectrodes into cohorts of animals (N ≥ 3) for at least two 
weeks and compared the FBR and/or recording performance versus controls.  All of these 
studies were performed in rats unless otherwise noted.  All histological comparisons were 
quantitative unless otherwise noted. 
 
1.10.1 The Effect of Materials 
The earliest studies focused on the choice of materials implanted in the brain.  These 
studies found that silver [60, 71, 118-120], copper [60, 71, 119, 121], iron [60, 71], and 
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room temperature vulcanization silicone [60] were unsuitable due to their toxicity in brain 
tissue.  Meanwhile gold, platinum, tantalum, tungsten, stainless steel, nichrome, iridium, 
silicon, and a wide range of insulating polymers all resulted in relatively similar FBRs [60, 
71, 118-120, 122-124].  These studies were performed in a variety of small animals.  It 
appeared most solid, chemically-inert, non-cytotoxic materials created a similar FBR, and 
that reducing the FBR below this level would likely require more sophisticated approaches. 
 
1.10.2 The Effect of Coatings 
Investigators have attached bioactive molecules to microelectrodes in order to reduce 
the FBR and improve neuronal proximity.  He et al. in 2006 coated planar silicon 
microelectrodes with a nanoscale layer of the ECM protein laminin-1 [125].  They found 
an increase in activated macrophages one day after implantation and slightly decreased 
activated macrophages and astrogliosis four weeks after implantation.  Neuronal cell 
density near the microelectrodes were similar.  He et al. in 2007 attached the anti-
inflammatory peptide α-melanocyte-stimulating hormone to planar silicon microelectrodes 
and reported decreased activated macrophages one and four weeks after implantation and 
decreased astrogliosis at four weeks [126].  Azemi et al. in 2011 coated planar silicon 
microelectrodes with the transmembrane protein L1, which mediates axonal growth and 
neuronal migration and survival [127].  They reported that L1-coated microelectrodes had 
increased numbers of neuronal cell bodies, increased axons, decreased astrogliosis, and 
decreased activated macrophages at all time points examined (one, four, and eight weeks).  
These studies implanted 3-4 animals per time point.  A remaining question is whether the 
bioactivity of the various attached molecules was responsible for the improvements or 
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some other aspect of the coating, since the controls were uncoated devices. 
Other investigators have coated microelectrodes with thin (< 1 µm) hydrogel coatings 
to reduce protein adsorption and cell adhesion.  Lu et al. in 2009 coated 1 mm diameter 
polydimethylsiloxane rods with a poly(vinyl alcohol)/poly(acrylic acid) interpenetrating 
network polymer and found reduced astrogliosis six weeks after implantation [128].  They 
did not characterize the hydrogel’s thickness, but based on their methods, it was likely thin.  
Rao et al. in 2012 coated polydimethylsiloxane rods with copolymer polyurethane and 
poly(ethylene glycol) (PEG) and reported reduced astrogliosis and increased numbers of 
neurons six weeks after implantation [129].  Gutowski et al. in 2014 applied an 
approximately 60 nm thick layer of copolymer poly(N-isopropylacrylamide) and acrylic 
acid (pNIPAm-co-AAc) crosslinked with PEG to planar silicon microelectrodes [130].  
They reported reductions in astrogliosis and, unfortunately, reductions in neuronal cell 
bodies 24 weeks after implantation.  Lee et al. in 2015 electrochemically deposited a 20-
40 nm thick coating of poly(pyrrole-hyaluronic acid) to the recording sites of planar silicon 
microelectrodes and to the entire surface of uninsulated iridium microwires [131].  They 
found reduced astrogliosis three weeks after implantation around the microwires only.  
Thus, thin hydrogel coatings appear to have positive effects in some cases. 
Thicker hydrogel coatings have also been employed.  Lind et al. in 2010 compared 
microwire bundles coated in a thin layer of gelatin to microwire bundles embedded in a 
300 µm diameter gelatin needle [132].  They found reduced activated macrophages around 
the gelatin needles one week after implantation, but no difference in activated macrophages 
or astrogliosis after six weeks.  They also found that gelatin needles without microwire 
bundles produced less (or often no) astrogliosis compared to stab wounds with metal 
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needles of the same diameter, suggesting that thick gelatin coatings may assist in reducing 
the injury of implantation.  Skousen et al. in 2014 coated planar silicon microelectrodes 
with a 400 µm thick layer of alginate and found reduced macrophages, activated 
macrophages, astrogliosis, and BBB leakage and increased neuronal cell bodies near the 
thickly-coated microelectrodes 16 weeks after implantation [58].  The investigators 
hypothesized that the hydrogel’s permeability to proinflammatory cytokines was 
responsible for the improvements, a mechanism of action that will be discussed in greater 
detail in Chapter 1.11.  Shen et al. in 2015 compared planar polydimethylsiloxane (PDMS) 
microelectrodes to thin parylene microelectrodes embedded in collagen and Matrigel, a 
commercially-available ECM product [133].  They reported reduced astrogliosis, reduced 
chondroitin sulfate proteoglycan (CSPG), and increased numbers of neurons near the ECM 
devices 16 weeks after implantation.  Thick hydrogel coatings appear to be an effective 
approach for reducing the FBR, although they may require some redesign of the device. 
 
1.10.3 The Effect of Systemically-Administered Drugs 
Systemic pharmacological interventions have also been explored.  Spataro et al. in 2005 
administered the anti-inflammatory drug dexamethasone once or once per day for six days 
following implantation of a planar silicon microelectrode [66].  They reported qualitatively 
decreased astrogliosis versus controls for both drug regimes one and six weeks after 
implantation, but also observed qualitatively increased numbers of macrophages and 
increased laminin in blood vessels.  Rennaker et al. in 2007 administered minocycline, an 
antibiotic with anti-inflammatory and neuroprotective properties, in the animals’ drinking 
water two days prior and five days following implantation of microwire arrays [134].  They 
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found reduced astrogliosis one and four weeks after implantation as well as improved 
longevity of recording performance.  Potter et al. in 2013 administered the antioxidant 
resveratrol the day before and during implantation of planar silicon microelectrodes [135].  
They reported increased numbers of neurons, increased levels of the antioxidant enzyme 
catalase, decreased ROS, decreased BBB leakage, and decreased levels of toll-like receptor 
4 (a marker of immune activation) two weeks after implantation, but not at four weeks.  
Meanwhile, they found decreased macrophages, decreased activated macrophages, 
decreased astrogliosis, and decreased cell nuclei at four weeks, but not at two weeks.  
Degenerating neurons (identified by Fluorojade-C) were decreased at both two and four 
weeks after implantation.  Potter-Baker et al. in 2015 followed up on their previous work 
by administering daily injections of resveratrol and reported decreased ROS and decreased 
BBB leakage at two weeks, but not at 16 weeks after implantation [136].  They reported 
no difference in activated macrophages or numbers of neurons, but reported qualitatively 
decreased neurodegeneration at 16 weeks.  Interestingly, daily saline injections decreased 
ROS but increased BBB leakage at two weeks. 
Genetic knockout experiments have been conducted to identify targets for 
pharmacological intervention.  Sawyer et al. in 2014 implanted planar silicon 
microelectrodes into MCP-1 knockout mice and reported increased numbers of neurons at 
two and eight weeks and decreased astrogliosis, BBB leakage, and macrophages at eight 
weeks [137].  They also found that daily injections of RS 102895, an antagonist of the 
MCP-1 receptor chemokine (C-C motif) receptor 2 (CCR2), increased numbers of neurons 
and decreased macrophages two weeks after implantation.  Kozai et al. in 2014 implanted 
planar silicon microelectrodes into caspase 1 knockout mice [138].  Caspase 1 is required 
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for production of IL-1β and also becomes upregulated during neuronal cell death and 
degeneration.  They found improved single unit recording performance in the knockout 
mice over a six-month experiment. 
Systemically-administered drugs are clearly able to have an impact on the FBR and 
require no redesign of the microelectrode array.  However, benefits will have to be weighed 
against side effects if these drugs are to be used in humans. 
 
1.10.4 The Effect of Local Drug Delivery 
Drug delivery close to the device-tissue interface has been pursued in order to increase 
local drug concentrations and avoid systemic side effects.  Purcell et al. in 2009 injected 
the cell cycle inhibitor flavopiridol into the lateral ventricles at the time of implantation of 
planar silicon microelectrodes and found that impedance was reduced but single unit 
recording performance was not improved during the four-week experiment [139].  They 
found no significant differences in astrogliosis, neuronal density, and non-neuronal cell 
density.  Misra et al. coated planar porous silicon microelectrodes with either dried saline 
or dried saline with Poloxamer 188, a PEG and poly(propylene glycol)-based triblock 
copolymer that seals ruptured cell membranes [140].  They reported reduced astrogliosis 
and activated macrophages two weeks after implantation, reduced astrogliosis four weeks 
after implantation, and no significant histological differences six weeks after implantation.  
Recording performance was unaffected.  Hayn et al. in 2015 implanted rats with 400 µm 
diameter cannulae and injected either artificial cerebrospinal fluid (aCSF) or aCSF plus the 
neuroprotective drug memantine at the time of implantation [141].  They reported increased 
numbers of neurons, decreased astrogliosis, and no significant difference in macrophages 
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at two and six weeks after implantation.  They also found that rats given memantine 
performed better on various behavioral tasks. 
Investigators have also pursued controlled release strategies.  Zhong et al. in 2007 
coated planar silicon electrodes with a nitrocellulose-dexamethasone mixture and reported 
reduced astrogliosis and reduced neural process loss in coated devices one and four weeks 
after implantation compared to uncoated devices [78].  Activated macrophages and CSPG 
were both reduced one week after implantation but not at four weeks.  Huang et al. in 2015 
coated planar silicon electrodes with a 30 µm thick layer of polydimethylsiloxane-modified 
N, O-carboxylic chitosan (PMSC) and oligo-proanthocyanidin (OPC) [142].  PMSC is 
semi-hydrophilic, slowly degradable, and can be chemically incorporated with the 
antioxidant and anti-inflammatory drug OPC.  The authors reported improved recording 
performance, decreased activated macrophages, decreased astrogliosis, and increased 
numbers of neurons associated with the coated devices over a four week indwelling period.  
In both these studies, since controls were uncoated, the effects may be due to the physical 
and chemical properties of the coatings rather than the drugs 
Purcell et al. in 2009 seeded neural stem cells into alginate wells in planar silicon 
microelectrodes, hypothesizing that the cells’ sustained release of neurotrophic factors 
would improve neuronal proximity to the device [143].  Cell-seeded devices had improved 
numbers of nearby neurons at one day and one week, but reduced numbers at six weeks 
and three months.  The authors concluded that degradation of alginate and death of the 





1.10.5 The Effect of Device Architecture 
Another approach under investigation is modification of microelectrode architecture.  
One simple modification is to reduce the size of the device.  Stice et al. in 2007 compared 
the responses to 30 µm diameter microwires to 15 µm diameter microwires with a 10 µm 
thick degradable poly(glycolic acid) (PGA) coating [144].  They reported reduced 
astrogliosis associated with the 15 µm microwires four weeks after implantation.  They 
also implanted 30 µm microwires with 10 µm thick PGA coatings and found their 
responses to be similar to the uncoated 30 µm microwires, suggesting that astrogliosis 
depended on the size of the non-degradable indwelling components, rather than the size of 
the device during insertion.  Thelin et al. in 2011 implanted rats with steel microwires 50 
or 200 µm in diameter and found reduced astrogliosis, reduced activated macrophages, and 
increased numbers of neurons near the smaller microwires 12 weeks after implantation 
[145]. 
Another simple modification is to increase the spacing between microelectrode shafts.  
This may reduce the FBR by preventing the FBR to each shaft from overlapping, and may 
also reduce implantation injury by sparing more blood vessels per area [146].  McConnell 
et al. in 2007 reported increased astrogliosis associated with four-shank planar silicon 
microelectrodes with 125 µm shank tip spacing compared to 200 µm spacing, four weeks 
after implantation [147].  The closer-spaced microelectrodes also happened to be smaller 
(30-100 µm wide tapered shank vs. 60-100 µm), so the effect of spacing outweighed the 
effect of device size.  A later study by McConnell et al. in 2009 using the same devices 
reported increased activated macrophages, increased astrogliosis, increased hemosiderin-
laden macrophages, reduced dendrites, and qualitatively reduced numbers of neurons near 
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the closer-spaced devices 16 weeks after implantation [72].  Lind et al. in 2012 attempted 
to establish an upper bound on the distance at which the FBRs of multiple devices interact 
[148].  They implanted rats with sets of five bundles of 32 13.5 µm diameter microwires 
embedded in 300 µm diameter gelatin needles (as in their 2010 study [132]) spaced 1 mm 
apart, and found that activated macrophages and astrogliosis were similar to single bundles, 
six weeks after implantation.  Thus spacing appears to affect the FBR if the spacing is 
below some threshold distance, somewhere between 125 µm and 1 mm. 
A more advanced modification has been to reduce device surface area using a lattice-
style architecture.  Seymour et al. in 2007 created devices that had a solid shank 48 µm 
thick and 70 µm wide with lattice features 5 µm thick and 4, 10, 30, or 100 µm wide 
extending off to one side [67].  They reported increased numbers of neurons and reduced 
numbers of nonneuronal cells around the outer edge of the lattice features compared to the 
shank, regardless of lattice thickness, four weeks after implantation.  Skousen et al. in 2011 
compared the FBR to solid planar silicon microelectrodes with lattice planar silicon 
microelectrodes and found decreased activated macrophages, decreased BBB leakage, and 
increased numbers of neurons near the lattice devices eight weeks after implantation [57].  
Both of these studies compared devices with identical penetrating profiles, so the difference 
in FBR is most likely related to the reduction in surface area available for protein 
adsorption/activation and macrophage attachment rather than implantation injury. 
 
1.10.6 The Effect of Mechanical Motion 
In addition to the presence of a foreign material surface, mechanical motion of the 
implant relative to tissue can aggravate the FBR.  Although this has long been observed in 
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highly mobile tissues such as muscle and subcutaneous compartments [149], recently 
investigators have explored whether the relatively small motions between a microelectrode 
and the brain can increase the FBR.  Such motions, sometimes called micromotions, result 
from breathing and pulsatile blood flow [150].  In addition, if the microelectrode is tethered 
to the skull, head movements may move the microelectrode whenever the brain moves 
within the intracranial space.  Biran et al. in 2007 reported that planar silicon 
microelectrodes tethered to the skull had increased activated macrophages, increased 
astrogliosis, reduced neuronal processes, and reduced numbers of neurons relative to 
microelectrodes free-floating in the brain four weeks after implantation [54].  The authors 
noted that other factors may be involved, such as the migration of meningeal fibroblasts 
down the microelectrode or the presence of bone screws, silicone, and acrylic.  Thelin et 
al. in 2011 reported that microwires tethered to the skull were associated with increased 
activated macrophages, increased astrogliosis, and increased size of the implant cavity, but 
similar numbers of neurons 12 weeks after implantation [145].  Therefore, tethering 
appears to increase the FBR.  Although tethering is typical for single unit recording studies, 
increasing the flexibility of the wire bundle between microelectrode and connector could 
reduce the effect of tethering.  Wireless transmitters have also been developed [151], 
although their FBR has not yet been compared to tethered devices. 
In order to separate the effects of tethering forces from other sources of motion, Lind 
et al. in 2013 implanted rats with 500 µm diameter parylene-coated needles made of either 
solid platinum or hollow carbon fiber [152].  Therefore, the only differences between the 
implants were increased inertial and gravity forces for the platinum implants due to their 
higher mass density (note that both implants were extremely stiff).  They reported increased 
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astrogliosis in brain tissue six weeks after implantation, but no significant difference in 
activated macrophages or numbers of neurons.  However, they did find increased activated 
macrophages adhered to explanted high-density implants.  These results suggest that 
increased inertial/gravity forces alone are sufficient to increase the FBR, although the effect 
was not as great as tethering to the skull. 
Reducing the stiffness of the device has also been proposed as a way to reduce motion 
by allowing the device to flex and move with brain tissue.  Harris et al. in 2011 created 203 
µm wide, 100 µm thick “mechanically adaptive” devices composed of poly(vinyl acetate) 
(PVAc) and cellulose whiskers that become soft upon implantation into brain tissue and 
compared their FBR to 50 µm diameter tungsten microwires coated with PVAc to a final 
diameter of 160 µm [153].  They reported increased numbers of neurons and decreased 
CSPG associated with the mechanically adaptive devices four weeks, but not eight weeks, 
after implantation.  They also reported more diffuse astrogliosis for the mechanically 
adaptive devices eight weeks after implantation.  Nguyen et al. in 2014 performed a similar 
experiment using 135 µm wide, 63 µm thick mechanically adaptive devices and 123 µm 
wide, 15 µm thick planar silicon devices coated with a 15 µm thick layer of PVAc [154].  
They reported decreased astrogliosis and decreased BBB leakage surrounding the 
mechanically adaptive devices 2, 8, and 16 weeks after implantation.  They found 
decreased labeling for macrophages and activated macrophages and increased numbers of 
neurons at 16 weeks only.  Increased device flexibility appears to reduce the FBR, although 
the shapes and surface chemistries of experimental and control devices in these studies 
were not completely identical. 
It is also important to note that the previously mentioned approaches of reducing device 
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size, adding thick hydrogel layers, and using lattice architecture may have the additional 
effects of increasing flexibility, providing a mechanical buffer, and increasing mechanical 
integration, respectively, so the success of these strategies may be partly explained by 
mechanical effects. 
 
1.10.7 The Effect of Device Type 
A handful of studies have compared completely different types of devices.  These 
studies will only be discussed briefly since numerous variables in the designs of the devices 
could explain the differences in recording performance and FBR. 
Ward et al. in 2009 implanted rats with microwire arrays, UEAs, and two types of 
planar silicon arrays [155]. Small cohorts and high variability prevented them from 
drawing comparative conclusions regarding recording performance and the FBR.  Kozai et 
al. in 2012 compared extremely small PEG-coated “microthread” electrodes to planar 
silicon devices and found improved performance and qualitatively reduced markers of the 
FBR for the microthread electrodes [156].  Saxena et al. in 2013 reported improved 
recording performance and reduced markers of the FBR for microwire arrays compared to 
planar silicon devices [80].  Karumbaiah et al. in 2013 compared the FBR and recording 
performance among a variety of different planar silicon, microwire, and UEA designs, and 
again found favorable results for microwire arrays [157].  Vitale et al. in 2015 compared 
carbon nanotube fiber electrodes against platinum-iridium microwires and reported a 
reduced FBR associated with the carbon nanotube fiber electrodes, although their 




1.11 Finite Element Modeling to Predict the FBR 
The studies reviewed in the preceding sections show that it is possible to modulate the 
FBR to intracortical microelectrodes using a variety of different strategies.  Almost all of 
these studies have been performed in rat, without recording single units, for eight weeks or 
less.  Therefore the next step will be to select the most promising strategies and test them 
in larger animals, using functional devices, for durations of several months or more. 
The trial-and-error approach of the studies in the preceding sections was necessary in 
order to identify workable strategies.  However, as these strategies move into more 
expensive and time-consuming experimental paradigms, it becomes increasingly important 
to narrow down the design space to avoid unnecessary experiments. 
In many fields of engineering, finite element modeling allows engineers to test and 
refine devices and structures in silico before full-scale testing.  Recently, the Tresco lab 
has developed a finite element model of the FBR to intracortical microelectrodes.  The 
model uses device geometry and the diffusive properties of brain tissue as inputs and 
provides predictions of the concentrations of proinflammatory cytokines in brain tissue 
surrounding a device as output.  Higher predicted proinflammatory cytokine concentrations 
are expected to correspond to an increased FBR.  While the model does not remotely 
approach the complexity of the FBR in vivo, it has been able to successfully predict the 
influence of device architecture and thick hydrogel coatings on the FBR in two studies by 
Skousen et al. [57, 58]. 
In Chapter 4, we continue validation of the model by comparing its predictions for the 
UEA to the in vivo results in Chapters 2-3.  Furthermore, we expand our conceptual 
understanding of the model by examining predictions for different proinflammatory 
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cytokines with different diffusive characteristics.  Finally, we demonstrate that the model 
can be used as an engineering tool to rationally design modifications to the UEA.  We 
expect that with continuing validation and refinement, the model will speed the process of 





BBB LEAKAGE, ASTROGLIOSIS, AND TISSUE LOSS 
CORRELATE WITH SILICON MICROELECTRODE 
ARRAY RECORDING PERFORMANCE 
 
Reprinted from Biomaterials, 53, Nolta N.F., Christensen M.B., Crane P.D., Skousen 
J.L., Tresco P.A., BBB leakage, astrogliosis, and tissue loss correlate with silicon 




The clinical usefulness of brain machine interfaces that employ penetrating silicon 
microelectrode arrays is limited by inconsistent performance at chronic time points.  While 
it is widely believed that elements of the foreign body response (FBR) contribute to 
inconsistent single unit recording performance, the relationships between the FBR and 
recording performance have not been well established.  To address this shortfall, we 
implanted 4X4 Utah Electrode Arrays into the cortex of 28 young adult rats, acquired 
electrophysiological recordings weekly for up to 12 weeks, used quantitative 
immunohistochemical methods to examine the intensity and spatial distribution of neural 
and FBR biomarkers, and examined whether relationships existed between biomarker 
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distribution and recording performance.  We observed that the FBR was characterized by 
persistent inflammation and consisted of typical biomarkers, including presumptive 
activated macrophages and activated microglia, astrogliosis, and plasma proteins indicative 
of blood-brain-barrier disruption, as well as general decreases in neuronal process 
distribution. However, unlike what has been described for recording electrodes that create 
only a single penetrating injury, substantial brain tissue loss generally in the shape of a 
pyramidal lesion cavity was observed at the implantation site.  Such lesions were also 
observed in stab wounded animals indicating that the damage was caused by vascular 
disruption at the time of implantation.  Using statistical approaches, we found that blood-
brain barrier leakiness and astrogliosis were both associated with reduced recording 
performance, and that tissue loss was negatively correlated with recording performance.  
Taken together, our data suggest that a reduction of vascular damage at the time of 
implantation either by design changes or use of hemostatic coatings coupled to a reduction 
of chronic inflammatory sequela will likely improve the recording performance of high 
density intracortical silicon microelectrode arrays over long indwelling periods and lead to 
enhanced clinical use of this promising technology. 
 
2.2 Introduction 
Intracortical or penetrating silicon microelectrode arrays can record neural information 
from neurons in deeper cortical layers and send the signals to a computer in real time.  This 
type of “brain-computer interface” or “brain-machine interface” has been a useful research 
approach and, more recently, has shown promise as a treatment for incurable neurological 
injuries and diseases.  It has been shown that silicon microelectrode arrays implanted in 
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motor cortex can allow individuals with tetraplegia to control computer cursors [27] and 
multiple degree-of-freedom robotic arms [5] with conscious thought. 
While such microelectrode recording arrays can function for several years in humans 
and other large animals [5, 23, 27, 28, 39], the majority exhibit inconsistent performance 
and fail to record single unit action potentials at much shorter time points.  Studies 
systematically examining microelectrode array recording performance in multiple subjects 
have reported that the quality (signal-to-noise ratio) and quantity of single unit action 
potentials recorded by arrays fluctuate unpredictably and generally decrease over time in 
rats [33-36], guinea pigs [22], cats [23, 37, 38], nonhuman primates [39], and humans 
[159]. 
While the precise mechanisms are unclear, some of these reliability issues have been 
attributed to hardware-related problems including material degradation [35, 36, 39], 
percutaneous connector failure [22, 33, 39], and infection [39].  Some failures, however, 
occur without any ostensible hardware-related issues and are likely related to changes in 
the cortical tissue near the device related to the foreign body response (FBR) or may be 
exacerbated by inflammation elsewhere in the body.  Our lack of knowledge about the 
biological mechanisms is a significant challenge to clinical implementation as FBR-related 
failures are poised to become the dominant failure mode after the engineering related 
problems are solved. 
Since device performance requires the presence of functioning neurons within about 
100 µm of the device’s recording sites [41], one hypothesis of biologically-driven device 
inconsistency and failure is that the foreign body response (FBR) and associated 
inflammatory sequelae lead to neuronal death or electrophysiological silencing.  Studies 
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have consistently reported the involvement of activated macrophages and microglia, 
secretion of pro-inflammatory cytokines, blood-brain barrier (BBB) leakiness, and 
reductions in neuron cell bodies, dendrites, and myelin near chronically implanted 
microelectrodes [52-62, 64, 65, 71, 72, 160].  Persistent inflammation, BBB leakiness, 
and/or neurodegeneration may cause neurons within the device’s recording range to 
become silenced in the unfavorable extracellular environment, or they may lose their 
connectivity to other circuitry and stop reliably producing recordable action potentials.  
Another issue is gross movement of the implanted array due to fibrous encapsulation driven 
by the FBR [37-39]. 
Besides the FBR, another concern, particularly with large, high-density microelectrode 
arrays, is the initial damage to blood vessels that occurs during implantation [63, 70, 161], 
which has the potential to damage adjacent brain tissue similar to that seen after ischemic 
[146] or hemorrhagic [162] stroke.  To better understand the impact of implantation injury, 
investigators have implanted devices and minutes later withdrawn them, then allowed the 
animals to recover (often called a “stab wound injury”).  For single-shank planar silicon 
devices [53, 59], four-shank planar silicon devices [72], and single microwires [71], the 
injury of device insertion alone is not sufficient to cause significant brain tissue loss or 
persistent inflammation in brain tissue beyond a few weeks.  For high-density 
microelectrode arrays with dozens of stiff, penetrating features separated by short 
distances, it has been shown that significant vascular injury occurs after implantation [63, 
69, 70], but to our knowledge no studies have examined the long-term outcome after a stab 
wound injury created with a high-density silicon microelectrode array. 
While the implantation injury and FBR to microwire and planar silicon devices with 
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one or a few microwires or shanks are well described in the rat brain, the FBR to high-
density microelectrode arrays with regularly spaced penetrating features is less well 
understood.  This is important since these are the types of devices used in nonhuman 
primate studies and preclinical trials in humans.  Therefore, to better understand the 
implantation injury and FBR of a more clinically relevant microelectrode recording array, 
we used a combined histological and electrophysiological approach to study stab wound 
injuries and the FBR to 4X4 Utah Electrode Arrays (UEAs) chronically implanted in young 
adult rat cortex, and examined whether the histological features of the FBR corresponded 
with changes in single unit recording performance. 
 
2.3 Materials and Methods 
2.3.1 Microelectrodes 
UEAs were purchased from Blackrock Microsystems, Salt Lake City, UT.  The arrays 
had a 4X4 rectangular grid of 1 mm long microelectrodes spaced 400 µm apart (Fig. 2.1 
A) and were similar in overall design to those used in nonhuman primate [39, 163] and 
 
 
Fig. 2.1.  (A) UEA before implantation. Scale bar = 1 mm.  (B) Electrophysiological 
recording session with an awake and behaving rat implanted with a UEA.  (C) 
Representative waveforms from a recording session in which single unit action potentials 
were isolated on 5 of the 16 microelectrodes. 
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clinical studies [5, 27].  The wiring diagram relating connector pins to the locations of 
microelectrodes on the array was supplied from the manufacturer.  For long-term 
implantation experiments, the UEA, connector, and associated wiring were fitted into a 
custom-fabricated polyurethane headstage, sterilized with ethylene oxide, and allowed to 
outgas for at least 12 h prior to surgery.  For stab wound injury experiments, UEAs with 
identical design but no associated wiring were glued to a stainless steel wire mounted 
perpendicular to the backside of the array (so that the array could be held in a stereotactic 
frame) and similarly sterilized and outgassed. 
 
2.3.2 Animal Surgery 
All procedures involving animals were approved by the University of Utah Animal 
Care and Use Committee.  Adult male Sprague-Dawley rats weighing approximately 300-
350 g (N=28) were anesthetized by isoflurane and their heads shaved.  The animals were 
positioned in a stereotactic frame and the scalp was disinfected with 70% isopropyl alcohol 
and betadyne.  A midline incision was made along the length of the skull and the exposed 
scalp was dried using cotton applicators.  A 3-4 mm diameter craniotomy was created over 
primary motor cortex using an air driven drill bit with sterile saline rinses to prevent 
excessive heating.  Holes for screw placement were created using a stereotactically 
mounted air driven dental drill.  The dura was pierced and reflected with a 25 gauge needle, 
and the UEA inserted into brain tissue by lightly pushing on the backside of the array with 
hand held forceps.  The reference wire was tucked beneath the edge of the craniotomy over 
the exposed surface of the brain and the ground wire was tunneled a short distance beneath 
the scalp posterior to the incision site.  The headstage assembly (including the mounted 
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UEA, ground/reference wires, and electrical connector) was then fixed to the skull using 
stainless steel screws and photocurable acrylic adhesive.  The incision was then sutured 
shut around the connector. Elizabethan collars (Kent Scientific, Torrington, CT) were used 
to prevent rats from manipulating the implant site after surgery.  Three additional rats were 
used to study the effect of implantation induced damage in the absence of the foreign body 
response.  For these stab wound injury experiments, each rat underwent a similar surgery, 
except that the array was implanted stereotactically and withdrawn two minutes later and 
no headstage assembly was employed. 
 
2.3.3 Electrophysiological Recordings 
Rats were allowed to recover for one week, after which neural recordings were obtained 
from freely moving animals (Fig. 2.1 B) for a period of five minutes at weekly intervals 
using a Cerebus data acquisition system (Blackrock Microsystems, Salt Lake City, UT) 
and analyzed offline using Plexon Offline Sorter (Plexon, Dallas, TX) (Fig.  2.1 C).  Single 
units were isolated in principal component space using a manually assisted sorting 
algorithm.  Signal-to-noise ratio (SNR) was determined by dividing the peak-to-peak 
amplitude of the average waveform of an isolated unit by the RMS noise floor on that 
microelectrode. 
 
2.3.4 Failure Analysis 
In order to track the cause and time course of device failure, animals were examined at 
each recording session for signs of mechanical failure (headstage/connector failure or 
broken lead wires) or for a loss of all or nearly all recordable single unit activity.  If there 
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were no observable hardware-related issues, failure was attributed to the FBR.  Animals 
with devices that failed were sacrificed within six hours in most cases.  Animals with 
devices that did not fail were sacrificed at week 12.  All animals were included in further 
histological investigations. 
 
2.3.5 Euthanasia and Tissue Preparation 
At sacrifice, rats were anesthetized and perfused transcardially with phosphate buffered 
saline (PBS) followed by 4% paraformaldehyde in PBS.  Their brains were removed from 
the skull and the arrays dissected free.  Brains and arrays were postfixed for 24 h in 4% 
paraformaldehyde and equilibrated in a 30% sucrose solution before 30 µm horizontal 
brain sections were obtained using a cryostat. 
 
2.3.6 Immunohistochemistry and Microscopy 
Free-floating brain sections were blocked overnight in PBS with 4% v/v goat serum 
(Invitrogen, Carlsbad, CA), 0.5% v/v Triton-X 100, and 0.1% sodium azide then incubated 
overnight with the following primary antibodies in blocking solution: CD68 (ED-1, AbD 
Serotec, Raleigh, NC, .25 µg/ml) to identify activated macrophages and microglia, IBA-1 
(Wako Chemicals USA, Inc., Richmond, VA, .5 µg/ml), IgG (biotinylated goat anti-rat 
IgG, Southern Biotec, .5 µg/ml) to assess BBB leakage, GFAP (DAKO North America 
Inc., Carpinteria, CA, 2.9 µg/ml) to examine astrocyte cytoskeleton location and 
hypertrophy, NF200 (Sigma, St. Louis, MO, 8 µg/ml) to examine the spatial distribution 
of axons, and biotinylated tomato lectin (Burlingame, CA, 4 µg/ml) to label blood vessels.  
Sections were then rinsed three times with PBS for 1 h each before being incubated 
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overnight in fluorescently labeled secondary antibodies plus 10 µM DAPI to label cell 
nuclei, then finally rinsed again three times with PBS for 1 h each.  All incubations were 
performed at room temperature on a rocker.  The same protocol was used on explanted 
arrays to identify adherent cell types. Sections were mounted on slides and coverslipped in 
Fluoromount-G (Southern Biotec) then imaged with a confocal microscope.  For retrieved 
arrays, images were taken using a confocal microscope 5x air objective or a 40x water 
objective with the array submersed in a petri dish.  Due to anti-mouse secondary antibody 
cross-reactivity with high concentrations of endogenous rat IgG in tissue sections, the IBA-
1 image was used to eliminate IBA-1-negative areas from some CD68 images, since all 
activated macrophages should also be IBA-1+.  All histological images are maximum 
intensity projections. 
 
2.3.7 Determination of Void Volume 
To calculate the volume of damaged neural tissue, 2D cavity areas in histological 
sections were manually described in Photoshop (Adobe Systems Inc., San Jose, CA) (Fig. 
2.5 B-C).  The prismoidal formula: 
 
was used to estimate the cavity volume V lying between two sequential sections separated 
by distance L and having 2D void areas A and B, then summed over all sections.  In 
addition, the extent of tissue shrinkage from histological processing was confirmed to be < 
2% (linear shrinkage) by measuring distances between microelectrode tracts in sections, 
which were known to be spaced 400 µm apart. 




(𝐴 + √𝐴𝐵 + 𝐵) 
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Systèmes SolidWorks Corporation, Waltham, MA) by tracing and manually registering 
histological sections then using the loft tool to form a solid. 
 
2.3.8 Statistics 
SNR values and average number of units per microelectrode for a subset of animals 
which had isolated units over multiple recording sessions were compared between the first 
and last successful recording sessions using a paired t-test.  SNR and immunohistochemical 
marker intensity values between edge and center microelectrodes at the last session were 
compared using Student’s t-test.  Outliers in the data were identified using an interquartile 
test, with outliers lying above or below 1.5*IQR (interquartile range) ± Q3 or Q1, 
respectively.  The proportions of microelectrodes with isolated single units for 
microelectrodes located in brain tissue versus microelectrodes associated with tissue loss 
areas were compared using a z-test for two population proportions.  P values below 0.05 
were considered significant. 
 
2.4 Results 
2.4.1. Failure Analysis 
Most devices failed within the first five weeks, the majority due to hardware-related 
issues (Fig. 2.2).  Of these, loosening or failure of the headstage was the predominant 
failure mechanism (ten animals).  Breakage of the wire bundle was also a major hardware-
related failure mode (five animals), but was mitigated by limiting animal grooming through  
the use of Elizabethan collars.  After the first two weeks, the FBR accounted for a 




Fig. 2.2.  Summary of recording failure modes over the course of the study.  Devices failed 
due to such hardware-related issues as headstage loosening and breakage of lead wires or 
due to reasons related to the foreign body response.  Two animals exhibited single unit 




12 week study endpoint. 
At dissection, six of the eleven devices that failed due to the FBR were either tilted to 
one side or observed in a more superficial location relative to their original implantation 
position. In these cases it appeared as though fibrotic tissue from the FBR and tissue 
remodeling associated with the lesion cavity worked in concert to cause the change in array 
position.  The arrays from these 6 animals were otherwise functioning properly at the time 
of sacrifice.  Their headstages were still firmly anchored to the skull and there was no 
observable damage to any of the wires or connections as indicated by physical inspection 






Recording performance was variable over time in individuals and generally decreased 
over the 12 week period.  Isolated single units were obtained from a total of 16 animals in 
this study. Of those, 10 animals had isolated single units in more than one recording session 
and are summarized in Fig. 2.3.  The average number of units per microelectrode decreased 
from .37 to .19 between the first and last successful recording sessions (p = 0.0002).  
Additionally, the average SNR of units decreased from 11.3 to 9.4 between the first and 





Fig. 2.3.  Summary of recording performance for animals which had isolated units on at 
least two recording sessions.  (Left) Number of single units isolated at each recording 
session for each animal over time.  (Right) First session and last session averages for each 
microelectrode position as viewed from the top of the 4X4 UEA.  Both the average number 
of units and the average SNR decreased significantly from the first to the last recording 
sessions (p = 0.002 and 0.01, respectively). 
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2.4.3 Explanted Arrays 
Microelectrode arrays from the animals with implant durations six weeks or less were, 
in all but one case, easily removed from the brain after intracardiac perfusion without 
tearing or removing brain tissue.  Retrieved arrays were uniformly covered with CD68 
immunoreactivty, indicative of activated macrophages and activated microglia (Fig. 2.4 
A).  The majority of cell nuclei on the explanted array co-localized with CD68 
immunoreactivity, suggesting that activated macrophages and activated microglia were the 
predominant cell types.  A small number of unidentified CD68- DAPI+ cells were also 
present. Most CD68+ cells were amoeboid in shape, but several were found to have fused 
into foreign body giant cells (FBGCs) (Fig. 2.4 B).  These FBGCs typically had 10-15 
nuclei and a flattened, spreading cytoplasm with IBA-1+ immunoreactivy at cell margins 
[164].  The arrays for the two 12-week animals had significantly greater amounts of CD68+ 
fibrotic tissue encapsulation on the underside of the array. 
 
2.4.4 Histological Description of the FBR 
The tissue response in both implanted animals and stab wounded animals included 
significant areas of cortical tissue loss and inflammation similar to lesions observed after 
ischemic [146] and hemorrhagic [162] stroke produced experimentally in rat cortex.  The 
lesions appeared as cavities on the brain surface and often contained darker tissue in the 
otherwise cleared, perfused brain tissue (Fig. 2.5 A).  The size and shape of the cavity was 
variable between animals but tended to have a jagged, pyramidal shape, with the pyramid’s 
base at the brain surface and the tip pointing down into cortex.  Fig. 2.5 D-G shows a 3D 







Fig. 2.4.  (A) Representative maximum-intensity projection of CD68 immunoreactivity 
(green) on the surface of a retrieved UEA.  The data indicates that activated macrophages 
were uniformly distributed across all tissue-contacting surfaces of the array.  Scale bar = 
500 µm.  Inset shows close-up of a microelectrode shaft.  Most cell nuclei (DAPI, blue) 
co-localized with CD68, suggesting that activated macrophages were the predominant 
adherent cell type.  Inset scale bar = 50 µm.  (B) Some CD68+ cells appeared to have fused 
into multinucleated foreign body giant cells (arrowheads).  These cells had 10-15 nuclei 
and a flattened, spreading cytoplasm with IBA-1+ immunoreactivy at cell margins [164].  
The other CD68+ cells tended to have smaller, amoeboid morphologies with CD68 and 






Fig. 2.5.  Measurement of surface brain tissue loss volume.  (A) Photograph of cortex after 
perfusion and device removal, showing a cavity and colored tissue.  (B) Horizontal serial 
sections through the depth of the implantation site shown in A imaged at constant 
magnification.  (C) Section images stacked together in SolidWorks with outlines.  (D) 
Stacked images filled in to create a solid 3D model of the brain.  (E) Close-up of cavity 
area.  (F) Scale model of UEA aligned in position.  Note that only tissue sections from 
halfway down the electrode shafts to a depth of 1 mm below the tips were rendered.  (G) 




the same animal shown in Fig. 2.6. 
The size of the cavity was variable from animal to animal.  For reference, the brain 
volume encompassed between all the 16 microelectrodes was 1.2 x 1.2 x 1 mm, or 1.44 
mm3. 19% of animals had a lesion cavity with a volume less than 0.72 mm3 (half of the 
brain volume between the microelectrodes), 31% had a cavity between half and the full 
volume, and 50% had a cavity volume larger than the array volume.  No clear trend was 
observed in lesion volume versus time.  It is worth noting that in all but one case, the rats 





Fig. 2.6.  Representative horizontal sections from an animal sacrificed at 4 wks showing 
cell nuclei (DAPI, blue), axons (NF200, yellow), activated macrophages (CD68/IBA-1 
colocalization, green), BBB leakage (IgG, red), and astrocyte cytoskeleton (GFAP, cyan).  
Sections from three different depths are shown; 3D view illustrates approximate position 
of sections relative to UEA.  Lacy, hypercellular, CD68+, IBA-1+, IgG+, NF200- areas of 
damaged neural tissue covered a large portion of the UEA footprint in superficial cortex (-
500 µm), while microelectrodes not near tissue loss areas had a FBR typical of single shank 
electrodes.  In deeper cortex, the tissue loss area was smaller.  Arrowheads indicate a region 
of increased CD68, IgG, and GFAP immunoreactivity and decreased NF200 




In with fragile, lacy, hypercellular tissue that was positive for CD68 (activated 
macrophages and activated microglia), what appeared to be blood constituents (perhaps 
from ongoing angiogenesis and uncleared vasculature), and IgG, but was not positive for 
neuronal antigens (Fig. 2.6).  Surrounding the cavity was a region of astrocytes with 
upregulated GFAP, CD68+ cells, IgG immunoreactivity indicating BBB leakiness, and 
decreased levels of NF200 immunoreactivity.  The lesion cavity was anisotropic with 
depth: generally, 500 µm below the brain surface, or halfway down the lengths of the 
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microelectrodes, the cavity was at least as wide as the footprint created by the square base 
section of the array; nearer the tips the cavity narrowed to occupy a smaller fraction of the 
array footprint; 500 µm below the microelectrode tips the cavity was rarely visible but there 
were frequently regions of upregulated GFAP immunoreactivity, increased IgG 
immunoreactivity, and decreased NF200 immunoreactivity surrounding larger blood 
vessels that resided below the array microelectrode tips (Fig. 2.6, arrowheads). 
Away from the cavity, the FBR to individual microelectrodes had a biomarker 
distribution similar to what has been previously described for implants with a single 
penetrating microelectrode shaft [52-62, 64, 65, 71, 72].  This included a layer of CD68+ 
activated macrophages and activated microglia at the biotic-abiotic interface, surrounded 
by a layer of increased GFAP immunoreactivity and a diffuse zone of IgG 
immunoreactivity, indicating leakage of the BBB near each microelectrode tract.  Axons 
could not be found in the CD68+ area immediately surrounding the microelectrode, but 
were present just outside that zone.  In some cases, axons showed a thicker, 
neuroregenerative phenotype that appeared to wrap around the microelectrode similar to 
that reported for microwire electrodes [52, 56, 61]. 
 
2.4.5 Stab Wound Injuries 
In stab wound injury experiments, the arrays were extracted two minutes after insertion 
using a stereotactic manipulator without difficulty.  Upon removal, the arrays were covered 
on their underside with blood but had no adherent brain tissue (Fig. 2.7 A).  The surface of 
the brain at the stab wound injury site showed signs of hemorrhage but no surface damage 




Fig. 2.7.  (A) UEA withdrawn two minutes after implantation into brain tissue, showing 
the presence of blood but no cortical tissue attached to the UEA.  (B) Representative 30 
µm coronal section of rat motor cortex showing blood vessel distribution (tomato lectin, 
purple) and a scale outline of a 4X4 UEA is superimposed to show that each microelectrode 
shaft can transect multiple blood vessels of various sizes.  Scale bars = 500 µm. 
 
 
However, after sacrifice four weeks later, stab wounded animals were found to have 
lesion cavities similar in size and shape to those observed in implanted animals.  Stab 
wounded animals showed reduced immunoreactivity for CD68 and a more compact border 
of GFAP upregulation at the margins of the cavity compared to implanted animals (Fig. 
2.8). 
Analysis of vasculature contralateral to the implant site allowed us to estimate that a 
significant number of blood vessels are transected during implantation of a 4X4 UEA. Fig. 
2.7 B shows a coronal view of blood vessels labeled with tomato lectin in rat cortex with 
an outline of a UEA, revealing how the dense vascularization of cortex makes vascular 
damage inevitable given the UEA’s architecture.  Many descending arterioles and hundreds 






Fig. 2.8.  Representative horizontal sections from an animal four weeks after surgery in 
which the UEA was implanted and removed two minutes later (stab wound injury) showing 
activated macrophages and microglia (CD68, green) as well as astrocyte cytoskeletonal 
upregulation (GFAP, cyan).  Sections from three different depths are shown; 3D view 
illustrates approximate position of sections relative to UEA.  Significant brain tissue loss 
was visible in superficial sections.  The degree of tissue loss was similar for stab wounds 
and implants, however CD68 immunoreactivity was reduced around stab wound cavities 




2.4.6 Relationships between Recording Performance and Histology 
At final recording sessions, the average SNR for microelectrodes on the edge of the 
array was 10.1, while the average for microelectrodes in the center was 7.9, a statistically 
significant difference (p = 0.05) (Fig. 2.9).  Quantification of immunofluorescent 
biomarker-associated signal intensity within a 100 µm radius of microelectrode tips 
revealed that center microelectrodes had significantly higher levels of GFAP and IgG 
immunoreactivity, indicating that astrogliosis and BBB leakiness were associated with 
reduced recording quality (Fig. 2.9). 
Based on histological images, each microelectrode recording tip was categorized as 
being in brain tissue or in a lesion cavity (Fig. 2.10 A).  Microelectrodes in brain tissue 
were significantly more likely to record single units, both at the last recording session (p = 




Fig. 2.9.  Quantification of FBR biomarkers within 100 µm of the 12 edge microelectrodes 
vs. the 4 center microelectrodes revealed significantly greater levels of GFAP and IgG, 
suggesting that astrogliosis and BBB leakiness were greater near center microelectrodes (p 
= .004 and .01, respectively).  Comparison of recording performance for edge 
microelectrodes vs. center microelectrodes at the last session revealed a significant deficit 





Fig. 2.10.  (A) Evaluation of the effect of tissue integrity on single unit recording 
performance.  First, microelectrode tracts were identified (arrows).  Microelectrodes were 
then classified as being in brain tissue or in a cavity.  Scale bar = 500 µm.  (B) Across all 
animals, microelectrodes located in intact brain tissue were significantly more likely to 
record single units, both at the last session (p = .01) and over all sessions (p = .001). 
 
 
Attempts to relate recording performance and the spatial distribution of other FBR 
biomarkers, as well as t-tests comparing average immunofluorescent signals for 
microelectrodes with single units vs. microelectrodes without single units and linear 
regression analysis of SNR values vs. immunofluorescent biomarker signals, yielded no 
statistically significant relationships. 
 
2.5 Discussion 
In this study, we found that the FBR to a 4X4 UEA in rat cortex differs from that of 
simpler devices that create a single penetrating injury.  Specifically, implantation results in 
a lesion consisting of a substantial loss of cortical tissue and shows a response characterized 
by persistent inflammation throughout the indwelling period.  We suspect that the wound 
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healing response likely involves continual tissue remodeling of the implantation site and 
beyond that may underlie the temporal changes in recording performance that have been 
described by others [22, 23, 33-39, 159] related to movement of the device and changes in 
the surrounding brain tissue.  We found that vascular injury at implantation is sufficient to 
create these lesions, and using a statistical approach, we also found that biomarkers of 
astrogliosis, BBB leakiness, and lesions were all associated with reduced recording 
performance. 
Available evidence suggests that vascular injury is the mechanism responsible for the 
loss of cortical tissue observed in this study. Since surface cavities were observed after four 
weeks in stab wounded animals, the mechanism of cavity formation is related to the initial 
injury of implantation and not solely caused by FBR-related inflammatory sequela.  The 
reduced amount of CD68 immunoreactivity in stab wounded animals at the cavity margin 
was likely due to the lack of an indwelling device providing a persistent inflammatory 
stimulus.  It is known that silicon microelectrode arrays sever, stretch, and burst blood 
vessels during implantation [70, 161], which was confirmed by our observations of 
bleeding at the brain surface after implantation and deposits of blood in histological 
sections. Moreover, experimental models of ischemic [146] and hemorrhagic [162] stroke 
in the rat both report losses of brain tissue similar to what we observed here. 
Varying amounts of vascular injury is therefore the most likely explanation for the 
differences in the FBR to complex devices like the UEA that consist of many regularly 
spaced microelectrode shafts and what has been observed with other devices that create a 
single penetrating injury.  There are a number of reasons why vascular damage would be 
more extensive for a high-density microelectrode array than for a microelectrode with a 
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single penetrating feature.  Most obviously, a larger number of closely spaced, rigid 
penetrating features means that the probability of hitting, stretching and damaging 
descending arterioles is increased. Also, a large number of penetrating features spaced at 
fixed intervals makes it difficult to avoid surface vessels, unlike with smaller devices that 
can be more strategically placed [165].  Furthermore, issues with tissue compression and 
shearing are greater for large, complex arrays and can cause vascular damage distal to the 
array [70].  Finally, disruption of multiple blood vessels may exacerbate the extent of 
neural tissue damage.  For example, Shih et al. found that occluding multiple cortical 
descending arterioles in proximity to one another produced a cavity similar to what we 
have observed, while occluding a single descending arteriole did not result in a large cavity, 
but rather a small region of neural cell death approximately 0.2 mm3 in volume [146].  In 
summary, high-density silicon microelectrode arrays likely cause more extensive vascular 
damage than microelectrodes with a single penetrating feature, which provides an 
explanation for the loss of brain tissue we observed in this study but had not previously 
observed with simpler devices we have studied using a similar approach [53-58]. 
Other investigators have implanted high-density microelectrode arrays in rats, and 
some, but not all, report areas of brain tissue loss.  Williams et al. reported “large acellular 
lesions” associated with some microelectrode tracts one week after implantation of a 20-
channel microwire array in rat cortex [166].  Saxena et al. implanted 16-channel microwire 
arrays for 16 weeks and presented histology from a rat with poor recording performance 
alongside a rat with superior performance, and though their analysis focused on 
quantification of immunofluorescent signals, a cavity representing lost neural tissue 
associated with about half of the microelectrodes is visible in the image of the poorly-
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performing device [80].  Finally, Ward et al. implanted a variety of microelectrode arrays 
into rats. While their histological images are difficult to interpret and only an N = 1 for 
each device is presented, there are areas of tissue loss in several of the figures [155]. 
Other studies do not report significant loss of brain tissue [34-36, 134, 167, 168].  Brain 
tissue loss may be underreported since most of the histological analysis has focused on the 
recording or tip regions of microelectrodes.  However, there may also be differences in 
device design or surgical approach that reduce the amount of vascular damage and thus 
affect lesion volume.  If this is indeed the case, it will be necessary to do controlled studies 
to identify optimal strategies, since neither rat strain, device type, electrode count, electrode 
spacing, dural removal, dural sealant, or insertion speed seem to provide a clear correlation 
with neural tissue loss when comparing such studies. 
Meanwhile, in larger animals, there are reports of device settling, where high density 
silicon arrays are found sunken inside a depression on the cortical surface [37-39, 68, 169, 
170].  This type of surface cavity has been observed at time points as short as seven days 
[169] and as long as multiple years [39], with a depth similar to what we observed in this 
study, although with a shape more closely matching the rectangular microelectrode array’s 
base.  Until more detailed histological evaluation of the area near the depression is carried 
out, ideally including stab wound injury experiments, it will be unclear whether such neural 
tissue loss is related to the initial vascular damage and /or subsequent tissue remodeling 
associated with the chronic foreign body response.  We also suspect that another failure 
mode, gross device movement, may be related to remodeling of adjacent brain tissue 
following the initial vascular damage.  Whether such movement may explain the 
inconsistent recording performance observed using such devices is unknown. The results 
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from this study would support the notion that both are involved, since fibrosis and tissue 
loss were associated with devices that had failed to record single units and were found 
displaced from the initial implantation site.  The method of anchoring the device to the 
skull may also be important. Our approach in this study was similar to that used in large 
animal studies in that the microelectrode array was allowed to float on the cortex supported 
only by its wire bundle.  
We also found that certain features of the FBR were associated with degradation of 
recording performance.  The finding that the reduced SNR for center microelectrodes 
corresponded to higher levels of GFAP and BBB leakiness (as evidenced by IgG 
immunoreactivity) supports similar conclusions by Prasad et al., who reported that elevated 
immunoreactivity for ferritin, an iron storage protein that is increased by hemorrhage 
and/or a leaky BBB, correlated with reduced electrode performance, although this 
relationship was not analyzed statistically [35, 36].  A leaky BBB would create an 
unfavorable ionic environment for neuronal signaling, as well as contribute to 
neuroinflammatory cascades that lead to neurodegeneration and demyelination. BBB 
leakiness may prevent the closest neurons from surviving and/or firing properly, reducing 
SNR by allowing only more distant neurons with lower SNR to be detectable. Increased 
GFAP immunoreactivity may contribute by changing the distance between sensed neurons 
and the recording surface.  Centrally located microelectrodes likely have increased BBB 
leakiness and GFAP immunoreactivity because they are surrounded on all sides by the 
vascular injury and FBRs of the other microelectrodes that provide a compounding source 
of proinflammatory cytokines and plasma proteins, while edge microelectrodes have 
healthy brain tissue on at least one side that may facilitate proinflammatory cytokine and 
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plasma protein clearance.  
Meanwhile, the location of a microelectrode in brain tissue rather than in a lesion area 
also was related to recording performance.  Lesion areas were mostly devoid of neurons 
and had a high amount of BBB leakiness and inflammation near their borders. 
Microelectrodes that were displaced from their original implantation site out of brain tissue 
would appear in a cavity area in such an analysis, so this also suggests that array movement, 
when it does occur, can be problematic for recording.  The lack of other significant 
correlations may have been due to the low statistical power of our study group size. It is 
also worth noting that the high incidence of hardware-related failures were likely related 
to the thin, growing skulls of rats at this age. 
Efforts by ourselves and other investigators have already shown some success in 
reducing the FBR, reducing BBB leakiness, and improving neuronal survival near 
chronically indwelling microelectrodes in studies in rats using single-shank silicon 
microelectrodes.  However, this study also suggests that if such strategies are to be 
extended to high-density microelectrode arrays with many closely-spaced penetrating 
features, the problem of vascular damage and tissue loss must also be addressed. A number 
of techniques may reduce vascular damage.  For example, decreasing the spatial density of 
microelectrodes is a straightforward approach. Lind et al. reported that multiple microwire 
bundles spaced 1 mm apart did not interact and were histologically similar to single 
microwire bundles [148], Liu et al. reported improved recording performance for sparse 
arrays (spacing 620 µm) versus dense arrays (spacing 380 µm) in cats in the first 125 days 
[23], and McConnell et al. reported reduced GFAP immunoreactivity surrounding four-
shank planar silicon probes with 200 µm versus 125 µm spacing in rats at four weeks [147].  
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Another idea would be to implant single microelectrodes one at a time (perhaps with 
robotic assistance) exclusively in locations in between surface vessels, which would reduce 
vascular damage [165].  Approaching the cortex from below, rather than through the pia, 
has been accomplished in nonhuman primates [28] and could reduce vascular damage by 
transecting the smaller end branches of vasculature while leaving the larger pial vessels 
and penetrating arterioles/venules intact.  It is also plausible that using softer and smaller 
microelectrodes may reduce vascular damage.  Lastly, administering neuroprotective drugs 
[146], limiting bleeding by using hemostatic agents, and using immunomodulatory therapy 
may help limit the secondary cell damage to neural tissue caused by inflammatory 
sequelae.  Our observation that away from the lesion cavity the FBR to edge 
microelectrodes appeared similar to that of a silicon microelectrode with a single 
penetrating feature is encouraging.  If the problem of vascular damage can be addressed, 
recent strides in reducing the FBR to single penetrating microelectrodes may be applicable 
to high-density silicon microelectrode arrays and eventually translate into improved device 
performance in clinical settings. 
 
2.6 Conclusions 
We found that the FBR to a 4X4 UEA in rats is not the same as the FBR to devices that 
create a single penetrating injury, in that the UEA causes a more significant lesion to brain 
tissue that manifests itself in a cavity devoid of neuronal elements.  Our results indicate 
that vascular damage is responsible for this difference in response. In addition we found 
that BBB leakiness, astrogliosis, and tissue loss were associated with reductions in 
recording performance.  Moving forward, next generation high-density single unit 
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recording microelectrode arrays should be designed to reduce vascular damage caused by 
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3.1 Abstract 
Available evidence suggests the brain and the immune system undergo changes with 
age that increase a person’s susceptibility to injury, inflammation, and neurodegeneration.  
Since a large proportion of potential brain-machine interface (BMI) patients are aged 
individuals, we studied the foreign body response (FBR) and recording performance in 18-
month-old rats implanted with a 4x4 Utah Electrode Array (UEA).  We found that single 
unit recording performance was more robust over the 12-week indwelling period compared 
to a similar study using the same device and a similar surgical approach in young adult 
rats.  Like the earlier study, the amount of neural tissue loss and astrogliosis was inversely 
correlated with recording performance.  A comprehensive forensic analysis suggested that 




and decreased grooming behavior, which together reduced forces on the headstage and 
extended recording lifetime.  The results indicate that advanced age is not a limiting factor 
for use of BMIs and further reinforces the notion that reducing implantation injury, the 
FBR, and headstage-related forces are important design goals for next-generation single 
unit recording arrays. 
 
3.2 Introduction 
Paralysis, which can result from a number of central nervous system diseases or 
injuries, currently affects 1 in 50 Americans [1].  Sixteen percent of these patients are 
completely unable to move a part of their body [1].  Meanwhile, limb loss affects 1 in 190 
Americans [3]. In both of these patient populations, the loss of specific motor functions 
imposes a significant lifelong burden on the patient’s comfort, productivity, and 
independence. 
BMIs are in development to restore motor functions for individuals with paralysis or 
limb loss.  Already, BMIs have provided patients with tetraplegia volitional control over 
computer cursors [27, 31] and robotic arms [4, 5].  Unfortunately, the performance and 
reliability of these systems are not robust enough for widespread clinical adoption. 
Available evidence suggests that reducing the FBR to the implanted microelectrode arrays 
may improve performance and reliability [35, 36, 171, 172]. 
The population of people with paralysis and limb loss includes a significant number of 
aged individuals.  Fifty-six percent of individuals with paralysis are over the age of 50, and 
33.5% are over 60 [1]. Eighty percent of individuals with limb loss are over 45, and 42% 
are over 65 [3].  Therefore, brain-machine interfaces should be evaluated in aged as well 
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as young subjects. Moreover, most young patients will eventually reach at least middle age.  
Even in the extreme case of high tetraplegia due to spinal cord injury, a 20-year-old patient 
who survives the first year after injury has a life expectancy of 57 years [81]. 
During aging, the immune system undergoes senescence.  Aged individuals have 
reduced numbers of naïve B and T cells, decreased stimulated phagocytosis and reactive 
oxygen species (ROS) production by neutrophils and macrophages, and dysregulation of 
cell signaling pathways [83, 84].  These changes result in delayed wound healing [97] and 
increased levels of proinflammatory cytokines [83, 84].  The brain also changes with age. 
Microglia, the brain’s tissue-resident macrophages, acquire a more reactive phenotype 
[99].  Microglia become larger and less ramified, express increased markers of activation 
such as major histocompatibility complex (MHC) class II and clusters of differentiation 68 
and 45 (CD68 and CD45), and produce higher levels of proinflammatory cytokines such 
as tumor necrosis factor alpha (TNF-α) and interleukins 1-β and 6 (IL1-β and IL-6) [100-
104]. Astrocytes become more numerous and hypertrophic [105].  Mild neuronal loss and 
reductions in dendrites and synapses occur naturally [106].  In addition, the aged brain 
becomes more susceptible to developing neurodegenerative diseases that involve more 
radical loss of brain tissue such as Alzheimer’s disease [107] and Parkinson’s disease 
[108].  The processes of immune senescence, inflammation, and neurodegeneration are 
thought to be linked to one another and are the subject of continued research. 
Due to these changes, aged patients may present a uniquely challenging environment 
for the successful integration and functioning of an intracortical microelectrode array.  
First, the injury of implantation may be greater in aged patients.  Aged patients have poorer 
clinical outcomes following brain injuries such as ischemic stroke [109], traumatic brain 
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injury [110], and aneurysmal subarachnoid hemorrhage [111], and aged rodent models 
show increased loss of neural tissue following experimental injuries [112, 113].  The 
implantation of a microelectrode also causes injury.  With small, simple devices, the injury 
of implantation alone is not sufficient to cause permanent loss of neural tissue.  This has 
been established by implanting a microelectrode, immediately withdrawing it, and 
histologically evaluating the implant site weeks later [53, 59, 71, 72].  Larger, more 
complex devices of the type used for BMIs create a more significant injury [70] that results 
in permanent loss of neural tissue [171].  Since microelectrodes can only record neural 
signals within about 100 µm of their recording sites [41], extensive tissue loss can reduce 
recording performance.  If implantation injury is exacerbated in aged individuals, reducing 
implantation injury will need to be a high priority for next-generation intracortical 
microelectrode arrays. 
Another concern is that aged patients may develop a more severe FBR to intracortical 
microelectrodes. Within two weeks, microelectrodes in brain tissue become covered with 
a layer of activated macrophages that secrete proinflammatory cytokines [53]. Astrocytes 
in the vicinity of these activated macrophages become hypertrophic and form a glial scar 
[52-61, 72, 171].  Plasma proteins such as immunoglobulin G (IgG), which are normally 
excluded by the blood-brain barrier (BBB), leak into brain extracellular space and activate 
macrophages and complement [55-59, 72, 171]. Demyelination [52, 55, 61] and 
degeneration of neuronal processes [52-54, 61, 72] accompany these reactions. This has 
led to the hypothesis that the FBR leads to recording inconsistency and failure by causing 




Support for this hypothesis is mounting. One study reported that increased levels of 
neurodegenerative protein products in blood samples were associated with reduced 
recording performance at chronic time points in rats [35]. Another study found that when 
rats were given an anti-inflammatory drug, recording performance was improved [134]. 
Another study reported that knockout mice missing an enzyme necessary for IL-1β 
production largely preserved their initial recording performance, in contrast to wild type 
mice whose performance declined throughout a 26-week experiment [138]. These and 
other studies [36, 171, 172] suggest that reducing the severity of the FBR may improve 
recording performance. In aged patients, since the immune system generates more 
inflammation and neural tissue is more sensitive to degeneration, reducing the FBR may 
be even more important for recording quality. 
Perhaps the most relevant data available are those comparing clinical outcomes from 
deep brain stimulation (DBS) devices implanted in young and aged patients. Aged patients 
receiving DBS electrodes have increased rates of complications [114], somewhat decreased 
clinical benefit [115-117], and increased rates of cognitive and behavioural impairments 
[117]. Despite these concerns, no studies to our knowledge have examined intracortical 
microelectrode arrays in aged animals.  Fig. 3.1 shows an analysis of 41 studies that have 
examined the FBR to intracortical microelectrodes in rats. The data indicate that there has 
been a strong preference for studying rats in the early part of adulthood. The ages of 
patients in human BMI studies are 25 [27], 52 [5], 58 [4, 31], and 66 [4], so it is known 
that recording is at least possible in some aged humans. In order to gain a better 
understanding of the effect of age on the FBR and recording performance, we implanted 





Fig. 3.1: Ages of rats used in 41 studies of the FBR to microelectrodes in the rat brain. The 





then compared these results against a previous study in young rats. 
 
3.3 Materials and Methods 
3.3.1 Microelectrodes 
UEAs were purchased from Blackrock Microsystems, Salt Lake City, UT.  The arrays 
had a 4x4 rectangular grid of 1 mm long microelectrodes spaced 400 µm apart (Fig. 3.2 A) 
and were similar in overall design to the 10x10 microelectrode recording arrays used in 
nonhuman primates [39, 163] and in clinical studies [5, 27].  The wiring diagram relating 
connector pins to the locations of each microelectrode on the array was supplied by the 
manufacturer so that discrete forensic evaluation of the FBR and single unit recording 
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Fig. 3.2.  Materials and methods.  (A) 4x4 UEA before implantation. Scale bar = 1 mm.  
(B) Aged rat headstage four weeks after implantation. Some screws are visible through the 
clear acrylic headstage.  (C) Waveforms from a recording session three weeks after 
implantation with 21 units on 13 channels.  (D) 18-month-old, 800 g rat alongside a 15-
week-old, 400 g rat. 
 
 
could be performed.  UEAs were sterilized with ethylene oxide and allowed to outgas for 
at least 12 h prior to surgery. 
 
3.3.2 Animal Surgery 
All procedures involving animals were approved by the University of Utah Animal 
Care and Use Committee.  Male Sprague Dawley retired breeder rats approximately eight 
months of age were fed ad libitum and housed in pairs until they became too large to share 
a single cage.  Rats were aged to at least 72 weeks before implantation. 
Eight rats were anesthetized with isoflurane and their heads were shaved.  The rats were 
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positioned in a stereotactic frame and the scalp was disinfected with 70% isopropyl alcohol 
and betadyne.  A midline incision was made along the length of the skull and the exposed 
scalp was dried using cotton applicators.  Four stainless steel screws (Fine Science Tools, 
Foster City, CA) were screwed into the skull after drilling pilot holes with a pneumatic 
dental drill.  A rectangular craniotomy approximately 3x5 mm was created over the right 
primary motor cortex using a pneumatic dental drill with sterile saline rinses to prevent 
excessive heating.  The dura was pierced and reflected with a 25 gauge needle.  The UEA’s 
associated connector was held in a stereotaxic manipulator, so that the UEA hung 
horizontally supported by the stiffness of the wire bundle, and was positioned over the 
craniotomy.  The UEA was then inserted into brain tissue by lightly pushing on the 
backside of the array with forceps.  The reference wire was also inserted into the brain 
using forceps.  The craniotomy was then covered with Kwik-Cast silicone (World Precision 
Instruments, Sarasota, FL).  After the silicone set, the UEA’s connector was positioned 
over the center of the skull and fixed in place between four screws set at angles into the 
cranial ridge using photocurable acrylic adhesive (1187-M, Dymax, Torrington, CT).  The 
ground wire was tunneled a short distance under the skin behind the head.  Fig. 3.2 B shows 
a close-up of the UEA connector and acrylic headstage in a rat four weeks after 
implantation. 
 
3.3.3 Electrophysiological Recordings 
Rats were allowed to recover for one week, after which time neural recordings were 
obtained from freely moving animals for a period of five minutes twice per week using a 
Cerebus data acquisition system (Blackrock Microsystems, Salt Lake City, UT) and 
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analyzed offline using Plexon Offline Sorter (Plexon, Dallas, TX) (Fig. 3.2 C).  Single units 
were isolated in principal component space using a manually assisted sorting algorithm.  
Signal-to-noise ratio (SNR) was determined by dividing the peak-to-peak amplitude of the 
average waveform of an isolated unit by the RMS noise floor on that microelectrode.  The 
recording performance for a particular week was determined using the better of the two 
sessions for each individual microelectrode on the array. 
 
3.3.4 Failure Analysis 
In order to track the cause and time course of device failure, animals were examined at 
each recording session for signs of headstage/connector failure, broken lead wires, or for a 
loss of recordable neural activity.  If there were no observable hardware-related issues and 
the UEA was still functional at the time of recording, then failure was attributed to the 
FBR.  Animals with devices that did not fail were sacrificed 12 weeks after implantation. 
 
3.3.5 Euthanasia and Tissue Preparation 
At sacrifice, rats were anesthetized and perfused transcardially with phosphate buffered 
saline pH 7.4 (PBS) followed by 4% paraformaldehyde in PBS.  Their brains were removed 
from the skull and the arrays dissected free.  Brains and arrays were postfixed for 24 h in 
4% paraformaldehyde in PBS and equilibrated in a 30% sucrose solution before 30 µm 





3.3.6 Immunohistochemistry and Microscopy 
Free-floating brain sections were incubated overnight in PBS with 4% v/v goat serum 
(Invitrogen, Carlsbad, CA), 0.5% v/v Triton-X 100, and 0.1% sodium azide then incubated 
overnight with the following primary antibodies in blocking solution: CD68 (ED-1, AbD 
Serotec, Raleigh, NC, .25 µg/ml) to identify activated macrophages and microglia, IBA-1 
(Wako Chemicals USA, Inc., Richmond, VA, .5 µg/ml) to label all macrophages and 
microglia, IgG (biotinylated goat anti-rat IgG, Southern Biotec, .5 µg/ml) to assess BBB 
leakage, GFAP (DAKO North America Inc., Carpinteria, CA, 2.9 µg/ml) to examine 
astrocyte cytoskeleton location and hypertrophy, NeuN (EMD Millipore, Billerica, MA, 1 
µg/ml) to identify neuronal nuclei, and NF160 (Sigma-Aldrich, St. Louis, MO, 5 µg/ml) to 
visualize axons/dendrites.  Sections were then rinsed three times with PBS for 1 h each 
before being incubated overnight with appropriate fluorescently labeled secondary 
antibodies plus 10 µM DAPI to label cell nuclei, then finally rinsed again three times with 
PBS for 1 h each.  All incubations were performed at room temperature on a rocker.  The 
same protocol was used on explanted arrays to identify adherent cell types.  Sections were 
mounted on slides and coverslipped in Fluoromount-G (Southern Biotec) then imaged with 
a confocal microscope.  For retrieved arrays, images were taken using a confocal 
microscope 5x air objective or a 40x water objective with the array submersed in PBS in a 
petri dish.  Due to anti-mouse secondary antibody cross-reactivity with high concentrations 
of endogenous rat IgG in tissue sections, the IBA-1 image was used to eliminate IBA-1-
negative areas from some CD68 images (since all activated macrophages should also be 
IBA-1+) and the IgG image was subtracted from the neuronal nuclei image to reduce the 
brightness of cross-reactive labeling.  These image adjustments were not performed on 
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images for quantification.  All histological images are maximum intensity projections. 
 
3.3.7 Measurement of Lesion Cavity Volume 
To calculate the volume of damaged neural tissue, 2D cavity areas in histological 
sections were manually described in Photoshop (Adobe Systems Inc., San Jose, CA).   The 
prismoidal formula: 
 
was used to estimate the cavity volume V lying between two sequential sections separated 
by distance L and having 2D void areas A and B, then summed over all sections.  
 
3.3.8 Image Quantification 
The adhesion of tissue to some but not all microelectrode shafts made traditional image 
quantification methods, where immunofluorescence is generally quantified beginning at 
the edge of the microelectrode track, impossible.  Instead, here immunofluorescence was 
quantified from the outer edge of the dense CD68+ layer if it was visible.  If it was not 
visible, the dense CD68+ layer was presumed to have adhered to the explanted 
microelectrode, and immunofluorescence was quantified from the edge of the track hole as 
usual.  Thus, measured immunofluorescence values represented the average 
immunofluorescence intensity of brain tissue outside the dense CD68+ layer in both cases 
and inside a circular 100 μm radius centered on the track for all microelectrode tracks, 
normalized to the average immunofluorescence in three 636x636 μm areas in a similar 








Outliers in the data were identified using an interquartile test, with outliers considered 
as those lying above or below 1.5*IQR (interquartile range) ± Q3 or Q1, respectively.  To 
better understand the relationship between recording performance and the FBR, we 
compared individual microelectrodes within a 4x4 array that recorded a single unit versus 
microelectrodes that did not over a variety of metrics using z-tests for two population 
proportions or Student’s t-tests.  P values below 0.05 were considered significant. 
 
3.4 Results 
3.4.1 Aged Rat Model 
Rats were aged in our animal facility to at least 18 months before implantation, reaching 
an average weight of 935 ± 135 g.  At this age the rats were obese, mostly sedentary, poorly 
groomed, and required softer bedding to control foot sores.   Fig. 3.2 D shows an implanted 
73-week-old rat next to a 15-week-old adult rat, an age typical for microelectrode array 
FBR studies [35, 36, 53-59, 67, 72, 78, 80, 134, 136, 147, 152, 153, 155, 156, 171]. 
 
3.4.2 Failure Analysis 
Failure modes are summarized in Fig. 3.3.  One animal died of unrelated complications 
of old age four weeks after implantation.  Another animal experienced a complete loss of 
recordings after five weeks.  Upon dissection, this animal was found to have a large white 
blood cell and macrophage-filled lesion cavity in the implant area.  Another animal’s 
headstage became detached after seven weeks.  The remaining five implanted animals 
continued to record single units through the 12-week study endpoint. 
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Fig. 3.3.  Summary of failure modes.  One animal died of old age and one was removed 
due to headstage removal.  Another animal had a complete loss of recording ability at five 
weeks despite a functional UEA and was found to have had a large white blood cell-filled 






In two of the eight animals, single unit action potentials could not be isolated during 
any of their recording sessions, even though their devices appeared to be recording 
electrical activity and there were no indications of any problems with the implantation or 
surgical recovery.  One of these animals died of old age four weeks after implantation and 
the other lost its headstage at seven weeks. 
In the other six animals, single unit action potentials were isolated on most recording 
sessions.  Recording performance varied across animals and across time, but was generally 
highest at weeks 3-4 and decreased thereafter (Fig. 3.4).  Peak performance, or the best 
recording session for each rat, was 12.7 ± 5.9 units.  Both the average number of units and 






Fig. 3.4: Summary of recording performance over time for the six animals that recorded 
units. (A) Individual performance.  (B) The average number of single units recorded was 
highest at weeks 3-4 and decreased thereafter. SNR slowly decreased over the indwelling 
period. Both of these negative correlations with time were significant at p < 0.001. 
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3.4.4 Explanted Arrays 
All of the explanted arrays were encapsulated in fibrotic tissue that was much thicker 
than the outer meningeal layers and was attached to the skull, making the dissection very 
difficult.  The amount of attached tissue ranged from just covering the base of the array (as 
shown in Fig. 3.5 A, N=4) to enveloping much of the array (N=4).  An 
immunohistochemical analysis of explanted arrays revealed that a large number of CD68+ 
activated macrophages/microglia were present in the adherent tissue, especially near the 








Fig. 3.5.  Explanted arrays.  (A) Representative photograph of a UEA explanted after 12 
weeks. The base was fully encapsulated, the shafts were partly encapsulated, and the tips 
were mostly free of tissue. Arrowhead indicates the electrode identified in Fig. 3.6. (B) 
Large numbers of activated macrophages (CD68) and cell nuclei (DAPI) are associated 
with the tissue on the retrieved UEA, especially at the base. Scale bar = 500 µm.  
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3.4.5 Description of the FBR 
After removing the brain from the skull, a lesion in the surface of the brain was visible 
where the UEA was previously seated.  The lesion cavities were variable in size and shape, 
but tended to be pyramidal, becoming narrower with depth into the cortex.  Perfused neural 
tissue at the margins of the lesion cavity also had a slightly darker color.  In four rats, the 
lesion appeared to encompass the entire array.  These were the same rats with explanted 
arrays that were completely encapsulated. In the other rats, the lesions were narrower and 
appeared to extend in some cases to the microelectrode tips.  These smaller lesion cavities 
were filled with fluid and lacy connective tissue with CD68+ activated macrophages 
present.  Fig. 3.6 A shows a reconstruction from histological sections of one such cavity in 
the same rat as shown in Fig. 3.5.  Lesion cavities were not always under the array and in 
some cases extended into adjacent brain regions.  The average lesion volume was 1.3 ± 0.6 
mm3. 
In horizontal sections, the lesion cavity appeared as a gap in the tissue (Fig 3.6 B-D).  
The border of the cavity had high immunoreactivity for IgG, decreased immunoreactivity 
for neuronal nuclei and neurofilament, and increased immunoreactivty for GFAP.  The 
cavities were partially filled with lacy, CD68+ tissue.  Microelectrode tracks were visible 
in cases where the array was not completely encapsulated.  Each microelectrode track fit 
one of two general descriptions: either they appeared as an empty hole in the section, or 
they appeared as a smaller empty hole surrounded by a dense ring of CD68+ 
immunoreactivity (Fig. 3.7).  The microelectrode tracks with little or no CD68+ 
immunoreactivity in tissue sections tended to correspond to microelectrodes that had more 







Fig. 3.6.  Description of the FBR.  (A) SolidWorks rendering of a deep but narrow lesion 
cavity in relation to one of the microelectrode tips (arrowhead).  (B) Horizontal section 
from the same animal showing BBB leakage (IgG) and neuronal nuclei (NeuN) at a depth 
near the tips of the 4x4 array of microelectrodes.  The microelectrode inside the lesion 
cavity in (a) is indicated with an arrowhead in (b-d).  Another, more narrow cavity 
extending off the edge of the array is indicated with an asterisk.  IgG was highly 
concentrated in lesion cavities and was minimally present in intact parenchyma.  Neural 
cell body loss was evident at the margins of lesion cavities.  (C) Hypertrophic astrocytes 
(GFAP) were visible around each microelectrode track and surrounding the lesion cavities.  
(D) Activated macrophages/microglia were present in the larger cavity and around some 






Fig. 3.7.  High-magnification view of two principal types of microelectrode tracks in 
horizontal sections taken at a depth near the tip.  The top row shows a representative 
microelectrode track that did not have a CD68+ sheath.  In this case, activated 
macrophages/microglia (CD68) were absent and the track hole was devoid of 
macrophages/microglia (IBA-1) and cell nuclei (DAPI).  Surrounding the track, BBB 
leakage (IgG) was minimal, neurons (NeuN/NF160) were absent inside the track, and 
astrocyte cytoskeletal intermediate filaments (GFAP) were slightly increased.  The bottom 
row shows a representative microelectrode tip section with a CD68+ sheath.  A compact, 
CD68+, IBA-1+, hypercellular sheath surrounded a small track hole. IgG, NeuN/NF160 
and GFAP appeared similar.  Scale bar = 100 µm. 
 
 
Stab-wounded animals (N = 5) sacrificed four weeks after implantation also had lesion 
cavities on the surface of their brains, with an average volume of 2.5 ± 1.3 mm3.  The 
general histological characteristics and gross appearance of such lesions in stab-wounded 
animals four weeks after stab wound injury were similar to lesion cavities in the implanted 
animals sacrificed at 12 weeks with the exception of the size difference.  No microelectrode 
tracks were visible in stab-wounded animal tissue sections. 
 
3.4.6 Analysis of Recording Performance and Histology 
In the final week of recording, all surviving animals had arrays that were able to record 
at least one single unit.  The arrays with the smallest lesion cavity volumes recorded the  
largest number of single units (Table 3.1).  The two arrays with the largest lesions and with 
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Table 3.1.  Summary of recording performance and gross characteristics of 12-week 
animals. 
 
Animal Electrodes with 





1952 8 0.86 Base only 
1954 5 0.85 Base only 
1950 2 2.22 Entire array 
1955 1 7.35 Entire array 
1953 1 1.21 Base only 
 
 
the largest amount of encapsulation tissue on the explanted arrays had only 1-2 
microelectrodes that were recording single units. 
Quantification of FBR-associated biomarkers in the brain tissue surrounding the 
recording tip revealed that reactivity for GFAP was significantly higher around 
microelectrodes that did not record units (p = 0.047) (Fig. 3.8).  Levels of CD68 and IgG 
were similar between microelectrodes that recorded at least one unit and those that did not. 
 
3.5 Discussion 
In this study, we implanted 18-month-old rats with 4x4 UEAs and examined recording 
performance over a 12-week indwelling period.  Based on a 25-month median lifespan for 
male Sprague Dawley breeder rats [173] and an 80-year median lifespan for American 
males [174], the equivalent human age for these rats was 53 years at implantation and 62 
years after the 12-week implant duration [175]. 




Fig. 3.8.  Quantification of FBR biomarkers in brain tissue within a 100 µm radius of the 
tip of individual microelectrodes.  Microelectrodes that recorded at least one unit in the 
final week of recording had significantly lower levels of astrocyte cytoskeleton (GFAP) (p 




previous study performed with younger adult rats using similar methods [171]. 
High recording performance in this study was surprising considering the relatively low 
performance in a previous study [171] and a body of literature that suggests that the 
biological effects of aging might decrease performance.  Peak performance was higher in 
aged rats, where the best recording session for each rat had 12.7 ± 5.9 units compared to 
8.1 ± 4.6 units in a younger cohort (p = 0.13) [171].  SNR was also similar, and in both 
studies gradually decreased.  The main difference was that, in this study, we were able to 
record single units on multiple sessions in 6 out of 8 aged rats, compared to 10 out of 28 
younger adult rats in the previous study (p = 0.049) [171].  Recording longevity was greatly 
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improved, with 5 out of 8 aged rats recording units after 12 weeks, compared to 2 out of 
28 young rats (p < 0.001).  Thus, it can be said that recording performance was more 
consistent across animals and over time in aged rats than in the previous study in young 
rats. 
The aged rat brain’s increased sensitivity to injury and inflammation, outlined in the 
introduction section, was expected to have a negative impact on recording performance.  
Although it is possible that features of the aged brain and immune system had a positive 
impact on single unit recording performance, we believe that other factors may be 
responsible for the differences observed. 
Aged rats have thicker skulls, and in this study, had lower physical activity and 
grooming behavior than one observes in younger adult rats.  The rat skull’s thickness 
increases rapidly during childhood and adolescence [176], and continues at a slower rate 
during adulthood.  Low physical activity levels are typical of aged, ad libitum-fed rats 
without exercise regimens [177].  The rigid acrylic headstages were well anchored at the 
end of the three-month indwelling period.  The data suggest that a combination of these 
factors reduced headstage-related failures and likely reduced movement translated to the 
indwelling microelectrode array.  Such motion has been proposed as an explanation for the 
increased FBR observed when a device implanted into the rat brain is fixed to the skull [54, 
145, 178], has high mass density [152], or has high stiffness [153]. 
We generally observed less immunoreactivity for IgG and CD68 in the aged rats in this 
study compared to an earlier published young adult rat study [171].  This is likely at least 
partly related to the longer implant durations in the aged rats.  IgG has been reported to 
decrease with time for single-shank planar silicon electrodes in rats [59] and mice [77]. 
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Literature on CD68 immunoreactivity describes reduced [36, 59, 72, 77] or not 
significantly different [35, 55, 56] levels of CD68 at 12 or more weeks compared to two or 
four weeks.  CD68 is indicative of phagocytosis by activated macrophages, so as cellular 
debris clearance reaches conclusion, less phagocytic activity is likely observed. 
The final notable difference between the aged rats in this study and the younger adult 
rats in a previous study was the increased amount of encapsulation tissue on explanted 
arrays in the aged rats.  In this study, encapsulation tissue was present on UEAs from all 
rats, whether they were sacrificed at 4, 5, 7, or 12 weeks.  The amount of tissue was variable 
and did not clearly correlate with time, however it did correlate with the volume of the 
lesion cavity in the brain.  It is likely that brain tissue lost due to implantation injury fills 
in with non-neural tissue, which may anchor or otherwise minimize movement of the 
microelectrode array.  Increased tissue adhering to individual microelectrode shafts 
explains the lack of a CD68+ sheath surrounding some microelectrode tracks in horizontal 
sections. In the previous study in younger adult rats, a large amount of encapsulation tissue 
was present on the two UEAs retrieved from rats 12 weeks after implantation [171].  In 
most of the other rats, however, the UEAs were cleanly removed from cortex, and an empty 
cavity with a small amount of lacy CD68+ tissue was found in tissue sections.  The most 
probable explanation is that non-neural encapsulation/fibrotic tissue accumulates at a 
variable rate beginning 2-5 weeks after implantation, after macrophages clear the lesion 
cavity. 
Recording performance was found to negatively correlate with lesion cavity size.  In 
this study and a previous study [171], lesion cavities occurred in both implanted and stab-
wounded rats, suggesting that neural tissue loss primarily results from the initial injury of 
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device implantation.  The lesion cavities were smaller in the implanted rats sacrificed at 12 
weeks than in the stab-wounded rats sacrificed at four weeks, possibly due to astroglial 
wound contracture.  Outside of our work, lesion cavities have only been reported in rats in 
a subset of studies that used high-density, multishank microelectrodes [80, 155, 166], and 
not in those using planar microelectrode arrays with one or a few shanks.  Williams et al. 
found significantly altered impedance spectra for microwires associated with lesions but 
did not attempt to record single units [166].  Saxena et al. and Ward et al. each show lesion 
cavities in their figures, but their N was too small for them to draw statistically-based 
conclusions [80, 155].  Two studies by Prasad et al. did not report any neural tissue loss, 
but did report that increased injury during implantation, as evidenced by bleeding, was 
associated with reduced recording performance [35, 36]. 
Reduced recording performance also correlated with increased levels of astrogliosis. 
We found that individual microelectrodes that did not record any units in the final week of 
recordings had significantly higher levels of GFAP immunoreactivity within a 100 µm 
radius of microelectrode tips in sections near the recording zone.  These findings agree 
with previous findings, in which higher levels of GFAP corresponded with reduced SNR 
for individual microelectrodes within the same array [171].  This relationship may be 
causal if hypertrophic astrocytes interfere with normal neuronal function in the vicinity of 
the microelectrodes, or it may be that GFAP immunoreactivity is a good indicator of subtle 
neuroinflammatory processes that reduce recording performance. 
A previous study found a relationship between BBB leakage (indicated by IgG) and 
recording performance [171], but that relationship was not statistically significant in this 
study.  It is likely that the overall lower levels of IgG in this study reduced its usefulness 
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as an indicator.  Another possibility is that the IgG present in the CD68+ sheath 
immediately adjacent to (and often removed with) the microelectrode would have been 
predictive of microelectrode performance, but could not be included in our quantification 
in this study.  Saxena et al. found that IgG was associated with reduced performance, but 
only when comparing two different types of devices, or when comparing just one high-
performing and one low-performing microwire array [80].  It is unclear how such a 
conclusion was drawn given the low N.  Two studies by Prasad et al. did not look at IgG, 
but rather ferritin, an iron storage protein found in macrophages after BBB disruption when 
iron sequestration is needed.  The researchers reported that higher levels of ferritin were 
associated with reduced performance, although this relationship was not supported by 
statistical methods [35, 36]. 
To summarize, we found that skull thickness, animal activity level, and use of well-
anchored headstages were likely responsible for improving single unit recording 
performance in aged rats relative to the younger adult rats in a previous study.  At the same 
time, we observed reduced markers of activated macrophages and BBB leakage as well as 
increased levels of encapsulation tissue, which may have been the result of reduced motion 
of the implant or an increased indwelling period.  Finally, we found additional evidence 
that increased astrogliosis and tissue loss correlated with decreased single unit recording 
performance. 
These findings have implications for studies in larger animals and humans.  They 
continue to support the idea that reducing the FBR and the impact of implantation injury 
are likely to improve chronic single unit recording performance.  This could be 
accomplished by reducing device surface area [57, 67], increasing device permeability 
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[58], reducing device size [156], reducing device stiffness [153], increasing spacing 
between microelectrodes [72, 147], administering drugs locally [78] or systemically [134, 
136], and implanting single-shank devices away from surface vessels [165], to name a few 
strategies that are supported by peer-reviewed studies. 
Furthermore, our results suggest that functional issues related to the headstage and wire 
bundle may be underappreciated.  Fibrotic tissue buildup that results in removal of the 
device from cortex has been described for UEAs in nonhuman primates [39] and cats [37, 
68] and for microwire arrays in cats [170].  Barrese et al., in a retrospective analysis of 
numerous experiments with UEAs in macaques, determined that 53% of all chronic 
(slowly-progressing) failures were due to fibrotic tissue buildup that either pushed or pulled 
the array out of cortical tissue [39], a similar rate of occurrence to a previous study [171].  
Solving this issue by fixing the microelectrode to the skull is not advisable in larger 
animals, since the brain has significantly more freedom to move within the cranium, but 
efforts to reduce the FBR and implantation injury may have the additional benefit of 
reducing the occurrence of this failure mode by reducing the amount of fibrotic tissue 
produced downstream of the initial vasculature damage.  Reducing tethering forces with 
extremely flexible wire bundles or wireless transmitters may also help. 
 
3.6 Conclusions 
Looking forward, the results of this study are encouraging for the future of BMIs.  If 
there are differences in recording performance and the FBR between young and aged 
animals, they do not appear dramatic enough to necessitate age-specific measures at this 
time.  This study provides support for the notion that BMIs, which have already achieved 
94 
 
exciting results in experimental trials in humans and nonhuman primates, will be able to 
perform even better if next-generation microelectrodes are designed to reduce implantation 





FINITE ELEMENT MODELING OF CYTOKINE DIFFUSION 
TO PREDICT THE FOREIGN BODY RESPONSE TO 
THE UTAH ELECTRODE ARRAY 
 
4.1 Abstract 
Microelectrodes have the potential to provide persons with disabilities volitional 
control over prosthetic devices.  However, a major issue with these devices is unreliable 
long-term recording of neural signals from brain tissue.  It is widely believed that the 
foreign body response (FBR) mounted against electrodes negatively impacts recording 
performance.  Therefore, strategies to reduce the FBR are expected to improve the 
reliability of microelectrodes and help bring this technology to the clinic.  Toward this end, 
we have developed a finite element model of cytokine diffusion.  This study applies the 
model for the first time to a large, complex, clinically-relevant device: the Utah Electrode 
Array (UEA).  Model predictions are validated with histological data in rats 4-12 weeks 
after implantation and cats 240-511 days after implantation.  We found that the model was 
successful in predicting features of the FBR, although it was more successful for the long-
duration implants in cats than for the shorter-duration implants in rats.  Next, we used the 
model to rationally design modifications for the UEA and found that reducing surface area 




Finally, we built a foundation for future improvements in the model by modeling the 
distribution of a variety of cytokines.  With further validation and refinement, the model 




Intracortical microelectrode arrays can record neural information from neurons in 
deeper cortical layers and send the signals to a computer in real time.  This type of “brain-
computer interface” or “brain-machine interface” (BMI) has been a useful research 
approach and, more recently, has shown promise as a way to restore functions lost to 
incurable neurological injuries and diseases.  Microelectrode arrays implanted in motor 
cortex can allow individuals with tetraplegia to control computer cursors [27] and multiple 
degree-of-freedom robotic arms [5] with conscious thought.  However, the clinical utility 
of these devices is limited by their inability to consistently record neural signals at chronic 
time points. 
Studies dating back to the 1950s have consistently reported the development of a 
foreign body response (FBR) to microelectrode arrays implanted into brain tissue.   This 
FBR involves activated macrophages and microglia, secretion of proinflammatory 
cytokines, blood-brain barrier (BBB) leakiness, and reductions in neuron cell bodies, 
dendrites, and myelin near chronically implanted microelectrodes [52-62, 64, 65, 71, 72, 
160].  Since microelectrodes can only record from neuronal cell bodies within about 100 
µm of the device’s recording sites [41], the FBR is believed to be associated with recording 
inconsistency.  Direct experimental evidence is accumulating in support of this claim [35, 
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36, 134, 171]. 
To improve recording performance, a number of investigators have attempted to 
modulate the FBR by modifying device design.  Device material composition [60, 71, 118-
124], bioactive coatings [125-127], protein-resistant coatings [128-131], thick hydrogel 
coatings [58, 132, 133], systemically-administered drugs [66, 134-136], locally-
administered drugs [78, 139-141], device size [144, 145], interelectrode spacing [72, 147], 
device surface area [57, 67],  and stiffness [153, 154] have all been reported to reduce the 
FBR in at least some cases.  To move the field forward, investigators will now need to 
select the most promising strategies and test them in larger animals, for long periods of 
time, in studies that include evaluations of recording performance. 
Finite element modeling allows engineers in many fields of engineering to design and 
test devices and structures in silico before full-scale testing.  Due to the high cost and time-
consuming nature of in vivo studies in the field of BMIs – especially studies using animals 
larger than rodents that include electrophysiological recordings – any tool that allows 
engineers to test designs in silico will greatly speed the process of optimization and testing. 
To fill this need, our lab has developed a finite element model of the FBR. 
Our model focuses on one particular aspect of the FBR: the diffusion of 
proinflammatory cytokines.  The model simulates production, diffusive transport, and 
degradation of proinflammatory cytokines in brain tissue.  High concentrations of 
proinflammatory cytokines are interpreted as areas of brain tissue likely to develop a more 
severe FBR. 
Proinflammatory cytokines are a crucial component of the FBR.  Adsorbed proteins on 
the surface of a device are recognized by macrophages [44], which secrete 
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proinflammatory cytokines such as monocyte chemotactic protein 1 (MCP-1), tumor 
necrosis factor alpha (TNF-α), interleukin 1β (IL-1β), recruiting and activating additional 
macrophages [42, 45].  The presence of macrophages on intracortical microelectrodes and 
their production of TNF-α and MCP-1 have been confirmed by culturing explanted 
microelectrodes [53].  Macrophages also secrete reactive oxygen species (ROS) [48] and 
vasoactive molecules such as nitric oxide (NO) [46].  In the brain, the combined result of 
these inflammatory processes includes BBB dysfunction, neuronal death, demyelination, 
and loss of neural processes. 
Thus far, two studies have been performed to validate the model.  Skousen et al. in 
2011 designed planar silicon microelectrodes with a lattice architecture that reduced the 
total surface area by about half [57].  The devices were implanted in rats for eight weeks 
and compared to solid planar silicon microelectrodes with identical penetrating profiles.  
The authors reported decreased immunoreactivity for activated macrophages, decreased 
BBB leakage, and increased numbers of neurons near the lattice devices.  This effect was 
successfully predicted by the model, since the lattice devices had less surface area available 
for macrophage attachment and therefore reduced quantities of proinflammatory cytokines 
being produced.  Skousen et al. in 2014 implanted rats with planar silicon microelectrodes 
coated with a 400 µm thick layer of alginate for 16 weeks [58].  They reported reduced 
macrophages, reduced activated macrophages, reduced astrogliosis, reduced BBB leakage, 
and increased numbers of neuronal cell bodies near the thickly-coated microelectrodes 
compared to both uncoated and nanoscale-coated devices.  This effect was also 
successfully predicted by our model, since alginate is permeable to proinflammatory 
cytokines and allows a portion of them to diffuse into the alginate layer and passively 
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degrade.  The fact that the reduced FBR resulting from these two distinctly different 
strategies was predicted by the model is certainly encouraging, but additional validation is 
needed. 
In this work, we applied the model to a larger and more complex device, the UEA, 
which is the only intracortical microelectrode currently used in humans.  Modeling results 
were validated with histological data in rats and cats.  Then, we explored whether the 
strategies of reducing surface area and adding a permeable hydrogel layer can be 
successfully adapted to the UEA.  Finally, we expanded our modeling efforts to a variety 
of proinflammatory cytokines in order to provide insights for future model improvements. 
 
4.3 Materials and Methods 
4.3.1 Finite Element Model 
Finite element modeling was performed in COMSOL (COMSOL Group, Stockholm, 
SE) using isotropic Fickian diffusion, a closed boundary at the top surface of the brain and 
open boundaries elsewhere, a 10 µm thick activated macrophage layer covering all device 
surfaces producing cytokines at a constant rate, and first-order decay of cytokines. 
Parameters were based on literature values and are summarized in Table 4.1.  Model 
geometry was based on photographic measurements of a 4x4 UEA.  Fig. 4.1 shows the 
photograph used, a side view of the modeled UEA, and the location of the 10 μm thick 
















Fibrinogen 8.22x10-12 48 h 4.01x10-6 1431 [179] 
H2O2 1.97x10
-10 7 min 1.65x10-3 328 [180] 
TNF-α 1.54x10-11 30 min 3.85x10-4 200 [181, 182] 
MCP-1 2.44x10-11 10 min 1.16x10-3 145 [183] 
IL-1β 2.21x10-11 7.5 min 1.54x10-3 120 [184] 
NO 1.20x10-10 5 s 1.39x10-1 36 [185] 
 
 
4.3.2 Validation Data 
Model predictions were validated qualitatively against immunohistochemical studies 
of 4x4 UEAs in rats and 10x10 UEAs in cats.  All procedures involving animals were 
approved by the University of Utah Animal Care and Use Committee.  Rat histological 
data were obtained from the previously published study by Nolta et al. in 2015 [171].  To 
briefly recapitulate their methods, 4x4 1 mm long UEAs with 400 μm interelectrode 
spacing were purchased from Blackrock Microsystems, Salt Lake City, UT.  The UEA, 
connector, and associated wiring were fitted into a custom-fabricated polyurethane 
headstage and implanted using stainless steel screws into 28 rats weighing 300-350 g for 
up to 12 weeks.  Elizabethan collars (Kent Scientific, Torrington, CT) were used to prevent 
rats from manipulating their headstages.  In order to investigate the effects of implantation 
injury without the presence of an indwelling device, three additional rats had a UEA was 










Fig. 4.1.  Modeling methods.  (A) Photograph of 4x4 UEA used for creation of model 
geometry.  (B) COMSOL model of 4x4 UEA geometry.  (C) Model predictions for TNF-
α concentrations surrounding a 4x4 UEA.  The view is a vertical cross section through four 
of the microelectrodes.  Dotted square represents frame of view in (D).  (D)  Close-up of 
the base of a UEA microelectrode shaft (asterisk) covered with 10 µm thick macrophage 
layer (arrowhead).  Color scale indicates percent relative to the peak predicted cytokine 
concentration of a 300 µm wide planar silicon microelectrode.  Scale bars = 500 µm in A-






Cats implanted with UEAs were received from the Neural Engineering Laboratory at 
the University of Utah (now at Arizona State University).  Three cats received 10x10 UEAs 
for 240 to 511 days.  The percutaneous connector was built into a pedestal fixed to the skull 
using screws. 
At sacrifice, rats and cats were anesthetized and perfused transcardially with phosphate  
buffered saline (PBS) followed by 4% paraformaldehyde in PBS.  Their brains were 
removed from the skull and the arrays dissected free.  Brains were postfixed for 24 h in 4% 
paraformaldehyde and equilibrated in a 30% sucrose solution before 30 µm horizontal 
brain sections were obtained using a cryostat.  Free-floating brain sections were blocked 
overnight in PBS with 4% v/v goat serum (Invitrogen, Carlsbad, CA), 0.5% v/v Triton-X 
100, and 0.1% sodium azide then incubated overnight with the following primary 
antibodies in blocking solution: IgG (biotinylated goat anti-rat IgG, Southern Biotec, .5 
µg/ml) to assess BBB leakage, NF200 (Sigma, St. Louis, MO, 8 µg/ml) to examine the 
spatial distribution of axons, NeuN (EMD Millipore, Billerica, MA, 1 µg/ml) to identify 
neuronal nuclei, GFAP (DAKO North America Inc., Carpinteria, CA, 2.9 µg/ml) to 
examine astrocyte cytoskeleton location and hypertrophy, and lectin to identify activated 
immune cells.  Sections were then rinsed three times with PBS for 1 h each before being 
incubated overnight in fluorescently labeled secondary antibodies plus 10 µM DAPI to 
label cell nuclei, then finally rinsed again three times with PBS for 1 h each.  All 
incubations were performed at room temperature on a rocker.  Sections were mounted on 






4.4.1 Model Predictions 
Predicted cytokine concentrations for the 4x4 and 10x10 UEAs are shown in diagonal 
cutaway in Fig. 4.2.  For both devices, cytokine concentrations were highest near the base 
of the array (i.e., superficial cortex) and gradually decreased along the lengths of the 
microelectrode shafts.  The peak cytokine concentration, corresponding to the base of the 
array, was 71% higher than the peak concentration predicted for a 300 µm wide planar 
silicon electrode, while the UEA microelectrode tips were much lower [57, 58].  Predicted 
concentrations were also slightly lower around microelectrodes on the outer edges of the 
arrays, an effect that was most pronounced near the base.  Non-edge microelectrodes had 
very similar cytokine concentrations to one another. 
The two different UEA designs had similar spatial distributions of cytokines.  The only 
observable difference was that the 10x10 UEA, with its longer microelectrode shafts, had 




Fig. 4.2.  Model predictions.  (A) Model predictions for TNF-α concentrations surrounding 
a 4x4 UEA.  The view is a diagonal cutaway. (B) Model predictions for 10x10 UEA shown 
at same scale.  Color scale indicates percent relative to the peak predicted cytokine 




4.4.2 Validation with Rats at 4-12 Weeks 
As previously reported by Nolta et al. in 2015 [171], gross inspection of rat cortex 
implanted with 4x4 UEAs revealed cavities of tissue loss in superficial cortex.  These 
cavities had a jagged, pyramidal shape with the pyramid’s base at the brain surface and the 
tip pointing down into cortex.  In horizontal sections, the cavities appeared as acellular 
gaps in the tissue, partially filled with lacy, hypercellular tissue positive for activated 
macrophages (CD68) and blood constitutents (IgG) and negative for axons (NF-200).  The 
border of the cavity had increased levels of astrocyte cytoskeleton (GFAP).  Away from 
the cavities, individual electrode tracks were visible.  Each track was surrounded by a layer 
of densely packed CD68+ cells.  This layer, in turn, was surrounded by a somewhat diffuse 
zone of increased IgG and GFAP. Stab-wounded rats sacrificed at 4 weeks showed 
similarly sized and shaped cavities, albeit with reduced macrophages and blood 
constituents, and showed no signs of electrode tracks. 
Predicted cytokine concentrations in horizontal planes corresponding to histological 
images are shown in Fig. 4.3.  The model predicts decreasing concentrations with depth 
into brain tissue.  BBB leakage (indicated by IgG) and loss of cortical tissue (indicated by 
areas lacking NF-200) associated with lesion cavities also decreased with depth.  However, 
markers of the FBR were relatively constant with depth surrounding individual 
microelectrode tracks that were not near lesion cavities. 
 
4.4.3 Validation with Cats at 240-511 Days 
Gross inspection of cat cortex implanted with 10x10 UEAs for 240-511 days showed 





Fig. 4.3.  Validation with rats.  Predicted TNF-α concentrations surrounding a 4x4 UEA 
shown in horizontal cross section at three different depths.  Also shown are representative 
30 µm horizontal sections at corresponding depths from a rat implanted with a 4x4 UEA 
for 4 weeks, labeled for blood constituents (IgG, green), cell nuclei (DAPI, blue), and axons 
(NF-200, yellow).  Color scale indicates percent relative to the peak predicted cytokine 
concentration of a 300 µm wide planar silicon microelectrode.  Scale bar = 500 µm. 
 
 
removed (Fig. 4.4).  The tissue immediately under the array was darkly colored, likely due 
to blood constitutents.  The square-shaped depression was mostly flat, but had some 
shallow irregularities in the surface. 
Modeling results (not shown) displayed the same spatial pattern described in Fig. 4.3 
of decreasing concentrations with depth.  In horizontal histological sections, small cavities 
of tissue loss were visible as well as lacy, hypercellular, non-neuronal tissue in superficial 




Fig. 4.4.  Validation with cats.  Gross image of implantation site of a 10x10 UEA in a cat 
for 511 days.  The implant site was cut vertically and is shown in cross section.  Settling 
of the UEA into tissue was apparent, as well as discoloration of cortical tissue.  30 µm 
horizontal sections at the depths indicated by the dotted lines labeled A and B are shown 
at right.  In (A), lacy, hypercellular, lectin+ tissue is visible towards the center of the array, 
while neural tissue is associated with microelectrode tracks at the edges.  Microelectrode 
tracks had hypercellular, lectin+ layers of cells surrounding them that were highly variable 
in thickness but tended to decrease with depth.  In (B), just below the microelectrode tips, 
little evidence of the FBR is apparent. 
 
 
than in the rats, but the lacy hypercellular tissue was equally extensive, suggesting that the 
cavities may become filled in with hypercellular tissue.  Tissue near the edge 
microelectrodes appeared relatively healthy.  Individual microelectrode tracks were 
surrounded by a layer of activated immune cells positive for lectin.  This layer was highly 
variable between electrode tracks, with no overarching spatial pattern.  However, unlike in 
rats, the thickness of this layer tended to decrease steadily with depth into brain cortex.  





4.4.4 Rational Design of Modified UEAs 
Three strategies to reduce the FBR were analyzed using the model and their predicted 
cytokine distributions are shown in Fig. 4.5.  Increasing the interelectrode spacing led to a 
13% reduction in the peak cytokine level compared to a standard 4x4 UEA.  The reduction 
was mostly localized to the spaces in between microelectrodes.   Creating 300 μm diameter 
holes in the base (allowing cytokines to diffuse out through the holes) reduced the peak 
cytokine level by 42%, and adding a 400 μm thick layer of alginate reduced the peak 
cytokine level by 50%.  Both of these last two strategies greatly reduced cytokine 
concentrations near the base of the array.  Concentrations near the tips were unaffected. 
 
4.4.5 Analysis of Other Solutes 
To develop a conceptual framework for characterizing the diffusion and degradation of 
other proinflammatory cytokines, we first obtained a closed-form solution to a simplified 
problem geometry.  In a system with an infinite plane wall producing a fixed flux of 
cytokines, isotropic Fickian diffusion, and 1st-order cytokine decay at equilibrium, the 
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where c is the concentration of cytokines, F is the flux of cytokines at the wall, D is the 
diffusion coefficient, k is the decay rate constant, and x is the distance from the wall.  In 
this simplified system, the concentration of cytokines decrease e-fold over a length constant 






Fig. 4.5.  Model geometry and predicted TNF-α concentrations associated with a standard 
4x4 UEA and three modified UEAs.  Peak cytokine concentrations for each modification 
are also listed.  Color scale indicates percent relative to the peak predicted cytokine 




coefficients, half-lives, decay rates, and length constants for fibrinogen, hydrogen peroxide 
(H2O2), TNF-α, MCP-1, IL-1β, and NO were calculated based on literature values are 
shown in Table 4.1. 
The analysis presented in Figs. 4.1-4.3 used diffusion and decay rate values for TNF-α 
and used the same color scale as in the studies by Skousen et al. [57, 58] in order to facilitate 
comparison with modeling results for planar silicon devices.  Next, we examined the 
predicted cytokine concentrations for other species and looked at their normalized 
concentration – in other words, the maximum for the color scale was set to the peak 
concentration in each simulation’s results.  Fibrinogen, with the longest length constant of 
1431 μm, diffused the farthest distance from the UEA (Fig. 4.6).  NO, with the shortest 
length constant of 36 μm, had a spatial distribution that conformed very closely to the 
device surface.  The other species had length constants and spatial distributions that were 
between these two extremes. 
 
4.5 Discussion 
In this study, we extended the validation of a finite element model of cytokine diffusion 
that was previously successful for single-shank devices [57, 58] to the larger and more 
complex UEA, and found that the model was most successful at predicting the FBR to the 
UEA in cats at 240-511 days after implantation.  We also used the model to rationally 
design modifications to the UEA and compared their predicted cytokine concentrations.  
Finally, we extended the model to additional proinflammatory cytokines besides TNF-α to 
provide insights for future improvements in the model. 








Fig. 4.6.  Predicted relative concentrations for five different soluble species.  Each species’ 
results are normalized so that the highest concentration is represented by dark red.  
Fibrinogen, with the longest length constant, diffused farthest from the UEA, while NO, 




Although the FBR decreased in intensity with depth, much of this response could be 
attributed to lesions from the injury of implantation, since it was visible four weeks after 
stab wound injury experiments that left no indwelling device.  The vascular damage from 
the implantation of a large, complex device such as the UEA [70, 171, 186] is significantly 
greater than it is for single-shank planar silicon devices [53, 59, 165].  The response 
associated with individual microelectrode tracks away from lesion cavities was relatively 
constant with depth, unlike modeling predictions.  It remains an open question whether the 
FBR would have been more similar to modeling predictions if the injury of implantation 
could be greatly reduced. 
Validation in cats 240-511 days after implantation was more successful.  Lesion 
cavities were smaller, and the lacy hypercellular tissue surrounding them tended to be more 
inflamed near the base and towards the center of the UEA.  The response to a stab wound 
injury from a 10x10 UEA in cat cortex is unknown, but the lesion cavities appeared to 
account for less of the response than in the rats.  This could be related to the longer implant 
duration, as damaged tissue and blood proteins are cleared away, and tissue remodeling, 
wound closure, and fibrosis have had time to fully develop.  There may also be differences 
in animal physiology.  Meanwhile, the intensity of the FBR associated with individual 
microelectrode tracks tended to decrease gradually with depth, as in the model.  The 
variability in the FBR to individual microelectrodes could be due to the proximity of blood 
vessels near particular microelectrodes. 
The model was also successful in predicting the high intensity (compared to the FBR 
around 300 μm wide planar silicon devices [57, 58]) of the FBR at the base of the UEA 
and the low intensity of the FBR at the tips of the UEA, especially in cats. 
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Modeling modified UEAs showed that the strategies of reducing surface area [57] and 
increasing permeability [58] can be successfully applied to the UEA to reduce predicted 
TNF-α levels.  We focused our efforts on the base of the UEA since the majority of 
proinflammatory cytokines accumulated in that region.  Even though the recording sites 
are at the tips, reducing the FBR to the base is still a worthwhile design goal for the 
following reasons.  First, the FBR to the base may be responsible for the settling of UEAs 
into – or fibrotic extrusion out of – cortical tissue observed in cats [37, 38, 68, 169, 170] 
and nonhuman primates [39], which causes the recording sites to move into suboptimal 
layers of cortex for recordings.  Second, destruction of superficial cortical layers may 
interfere with proper operation of cortical circuits.  Finally, inflammation anywhere in the 
brain can impact neurogenesis [187] and may contribute to side effects such as cognitive 
decline seen in patients receiving deep brain stimulators and hydrocephalic shunts [188].  
Modifying the UEA by adding a permeable layer of alginate achieved the greatest reduction 
out of the modifications proposed, followed closely by the base with reduced surface area, 
suggesting that these two strategies are likely to be successful for the UEA. 
Our model in its current state is an extremely simple representation of the FBR in vivo.  
In order to lay the groundwork for model improvements, we explored additional cytokines 
and soluble factors besides TNF-α.  We found that the distribution of a particular soluble 
species near a device can be conveniently characterized by a length constant equal to the 
square root of its diffusion coefficient over its decay rate.  Different soluble species were 
found to have cytokine distributions that extended various distances into tissue 
corresponding to their length constants.  Future improvements to the model may 
incorporate contributions from multiple soluble species and sum their contributions in 
113 
 
order to more accurately match validation data. 
 
4.6 Conclusions 
In this work, a finite element model of cytokine diffusion was applied to the UEA and 
validated with rats implanted for 4-12 weeks and cats implanted for 240-511 days.  The 
model successfully predicted the intense FBR to the base of the UEA and relatively minor 
FBR at the microelectrode tips.  The distribution of FBR biomarkers was most similar to 
model predictions in cats, where the effect of the initial implantation injury had partly 
subsided.  Examination of modified UEA designs showed that reducing surface area and 
adding a permeable cytokine layer are both likely to be effective strategies to reduce the 
FBR to the UEA.  Finally, the distribution of various other cytokines was predicted.  With 
additional validation and refinement, this model may grow into a powerful tool for 






SUMMARY, CONCLUSIONS, AND FUTURE WORK 
 
5.1 Summary and Conclusions 
Paralysis and limb loss often result in devastating and permanent disabilities for the 
persons affected.  Brain machine interfaces offer the hope of restoring lost functions by 
allowing the brain to directly control external devices via volitional thought.  The clinical 
utility of these devices is currently limited by the inconsistent performance of intracortical 
microelectrodes at chronic time points.  Available evidence suggests that the FBR to 
intracortical electrodes likely contributes to inconsistent performance, but little is known 
about the exact mechanisms responsible. 
In Chapter 2, a large cohort of young adult rats was implanted with 4x4 UEAs for up 
to 12 weeks.  This study provided the first in-depth description of the FBR to the UEA in 
the rat.  This allowed the FBR to the UEA to be compared with the extensive literature on 
the FBR to simpler devices implanted into rats.  It was found that the FBR to the UEA 
differs from the FBR to simpler devices in that the injury of implantation plays a much 
greater role in the long-term response, likely due to the increased potential for vascular 
injury from the multiple penetrating features of the UEA.  The effects of implantation 




associated with reduced recording performance.  We also found evidence that astrogliosis 
and BBB leakage correlated with decreased SNR for electrodes towards the center of the 
UEA.  These findings contribute to the field by drawing attention to the importance of 
minimizing vascular damage for large, complex microelectrode arrays, and by providing 
evidence that astrogliosis and BBB leakage are components of the FBR that are related to 
recording performance. 
In Chapter 3, a cohort of aged rats was implanted with 4x4 UEAs for up to 12 weeks.  
Although we expected to find increased inflammation and decreased recording 
performance due to the animals’ aged immune systems, we found overall higher recording 
performance compared to the young cohort and a comparable level of inflammation.  These 
findings suggest that recording quality may be dependent on animal activity level, skull 
thickness, and method of fixation to the skull.  These findings are also encouraging for the 
field of BMIs, since aged humans represent a large share of patients likely to receive 
intracortical microelectrode arrays.  Lastly, we found additional evidence that astrogliosis 
and tissue loss are associated with reduced recording performance. 
In Chapter 4, we extended our previous work modeling the production, diffusion, and 
decay of proinflammatory cytokines near single-shank planar silicon devices to the more 
complex geometry of the UEA.  We found that the model predicted increased 
concentrations of proinflammatory cytokines towards the center and towards the base of 
the UEA, suggesting that the FBR would be the most intense in these areas.  Validating 
these predictions against histological data from our studies of the UEA in rats and cats 
revealed that these predictions corresponded well to the actual distribution of the FBR in 
cats implanted for 240-511 days but only somewhat well in rats implanted for 4-12 weeks.  
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We then found that the strategies of reducing device surface area and adding a permeable 
layer of alginate could be successfully adapted to reduce the FBR to the UEA.  Finally, we 
modeled the distribution of a variety of soluble species and found that different species 
likely conform more or less closely to the device.  The validation of UEA modeling data, 
and the analysis of multiple soluble species, will be useful to future efforts to refine and 
expand the finite element model. 
 
5.2 Future Work 
One possible direction to proceed in the future would be to extend the work of Chapter 
2 and press further towards the goal of understanding the mechanisms of recording 
inconsistency.  This work provided evidence that astrogliosis, tissue loss, and BBB leakage 
are associated with recording inconsistency.  These correlations are statistically significant, 
but they fall short of providing a complete explanation for recording inconsistency.  For 
each of these markers, a high degree of variability was observed, and there were numerous 
exceptional cases, e.g., electrodes with high GFAP and high performance.  It may be that 
numerous processes simultaneously contribute to recording inconsistency, so that only the 
collection of processes can explain recording consistency and no single metric is sufficient.  
Or, it may be that there is a more reliable marker for recording inconsistency, and the 
markers we have found to correlate thus far are merely unreliable indicators of a more 
proximal cause.  A future study could use a similar approach to the studies in Chapters 2 
and 3, but make significant improvements in methodology based on what was learned from 
this work, such as: use of a large cohort of middle-aged or aged rats; use of a microelectrode 
that creates less vascular damage; use of a device that does not need to be explanted prior 
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to histology; development of histological techniques that can image a cube of tissue 
containing the device without explanting it; implantation into another area of cortex and 
using protocols to create evoked potentials in order to obtain action potentials more reliably 
[32, 37, 68, 69]; and use of immunolabeling techniques that reduce the impact of IgG cross-
reactivity and hemosiderin autofluorescence [189].  There are other factors that could be 
added to the analysis as well, such as electrode impedance, pre- and post-explant analysis 
of device materials integrity, and measurement of blood pNF-H levels, as in the two studies 
by Prasad et al. [35, 36].  Refining our approach may provide a clearer picture of the 
mechanisms of recording inconsistency than could be gained in these first efforts. 
A different direction would be to instead use the knowledge gained from this work and 
previous literature to design a next-generation device.  The ultimate goal of bioengineering 
is to provide patients with better medical technologies, and at this stage there are already 
multiple strategies that are ripe for further testing.  Demonstrating improved single unit 
recording performance for a modified UEA would be the fastest route towards clinical use, 
since the UEA is already used in humans.  Potential modifications could include those 
described in Chapter 4 (increased interelectrode spacing, decreased surface area, and 
addition of a permeable layer), modifications designed to reduce the effects of implantation 
injury (increased interelectrode spacing or coating the device with hemostatic materials), 
or pharmacological interventions [66, 134, 135, 139, 146].  If it could be demonstrated that 
the modified UEAs performed more reliably than the standard UEA, this would be 
unprecedented in the field, which has so far only examined modifications to planar silicon 
and microwire devices, and has only rarely performed chronic recording experiments using 




Although modifying the UEA has the potential to provide the greatest clinical benefit 
to the field in the near term, it is likely that the UEA will eventually be leapfrogged by 
another technology.  As investigators push towards richer, higher-fidelity BMI control, 
ever greater numbers of neurons will need to be recorded from [17, 40].  Since the UEA 
has microelectrodes that are regularly spaced and are inserted all at once, as microelectrode 
density increases, the difficulty of implantation and the potential for vascular damage 
become prohibitive.  An approach that would allow for a greater density of microelectrodes 
to be implanted into brain tissue would be to image the brain’s vasculature, then 
individually implant microwire electrodes in locations that avoid the larger blood vessels, 
an approach which has been accomplished for planar silicon devices [165].  Robotic 
surgery would be advisable if a very large number of microwires are to be implanted.  
Using extremely small microwires would have the added benefit of reducing the FBR [144, 
145, 156].  The main challenge with this approach is in connecting the microwires to 
recording equipment, as individually-wired connections may become unmanageable for 
large numbers of microwires.  It may be possible to communicate with the microwires 
wirelessly via light, ultrasound [190], or radiofrequency signals, especially if the 
microwires are only designed to communicate threshold events, rather than high-fidelity, 
highly temporally-resolved waveforms.  If so, this would further reduce the FBR by 
reducing tethering forces [54, 145].  A vast improvement in density accompanied by a 
decrease in the FBR could greatly improve performance and be transformative in the field 
of BMI and for brain research in general. 
With regards to the finite element model, a promising future direction would be to 
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perform quantitative validation.  In fields such as electrical engineering, physics, 
mechanical engineering, and materials science, quantitative data can be closely matched 
against model predictions.  Even in bioengineering, biomechanical models are subjected to 
quantitative validation [191].  In our model of the foreign body response, however, there 
is a leap from quantitative cytokine concentration predictions to the complex, qualitative 
description of histological biomarkers used as validation data.  To provide a more 
convincing case for the model’s validity, future experiments could be designed to validate 
predicted cytokine concentrations against actual measured cytokine concentrations.  This 
could be accomplished by using a device capable of sensing concentrations of cytokines or 
other soluble species, e.g., using cyclic voltammetry [192-195].  Soluble species could be 
measured over time, on differently-designed devices, and on different parts of the device 
in order to provide a rich dataset for model validation.  While measuring soluble species 
concentrations would be ideal, quantitative validation could also be carried out with 
histological markers.  Our lab is well acquainted with histological quantification techniques 
([53-58] and this work), so the primary challenge would be adapting the model so that it 
predicts GFAP, IgG, neurofilament, or CD68 immunoreactivity, or NeuN cell counts.  
Direct, quantitative validation would be significantly more convincing than the qualitative 
validation of the downstream effects of cytokines performed so far. 
As a side note, due to the influence of implantation injury, it would be wise to use 
small, single-shank microelectrodes for further development of the model.  Or, 
implantation injury could be modeled and validated using stab wound injuries.  As seen in 
this work, implantation injury is significant for large, complex microelectrode arrays.  
Therefore, a finite element model for implantation injury may be nearly as useful to 
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engineers as a model for the FBR.  Eventually, the FBR and implantation injury models 
could be combined. 
In addition to quantitative validation, it would also be convincing to explore situations 
in which the model makes unexpected predictions, and then test whether those predictions 
are correct.  This has already been observed in a few reports.  Increased inflammation on 
the inside corners of microelectrodes has been reported [67], which aligns with our model 
predictions, but not with predictions based on mechanical motion.  Decreased or equivalent 
FBR at the tips of microelectrodes [37, 55, 56, 171], successfully predicted by our model, 
also runs contrary to mechanical modeling which reports the highest tissue strains at the 
microelectrode tips [196].  The decreased FBR surrounding thick hydrogels [58] and 
hollow-fiber membranes [181] is also surprising, considering the increased size of these 
devices.  Ideas for future studies along this line of inquiry include: studying the FBR to 
parallel plates (the model would predict a severe FBR between plates that are placed close 
together), studying the FBR to hollow fiber membranes or hydrogel cylinders of varying 
diameter (the model would predict a more severe FBR for devices in a particular size range 
where macrophage attachment area is high but device permeability is not yet a significant 
factor), and comparing a device with a permeable grating and hollow interior vs. a device 
with an identical grating but a filled-in interior (the devices would be nearly identical in all 
respects except permeability).  If cases where model predictions outperform traditional 
predictions based on size and mechanical motion continue to accumulate, the model will 
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